0001683168-19-002622.txt : 20190814 0001683168-19-002622.hdr.sgml : 20190814 20190814160229 ACCESSION NUMBER: 0001683168-19-002622 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QS Energy, Inc. CENTRAL INDEX KEY: 0001103795 STANDARD INDUSTRIAL CLASSIFICATION: OIL & GAS FILED MACHINERY & EQUIPMENT [3533] IRS NUMBER: 522088326 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-29185 FILM NUMBER: 191026121 BUSINESS ADDRESS: STREET 1: 23902 FM 2978 CITY: TOMBALL STATE: TX ZIP: 77375 BUSINESS PHONE: 805-845-3581 MAIL ADDRESS: STREET 1: 23902 FM 2978 CITY: TOMBALL STATE: TX ZIP: 77375 FORMER COMPANY: FORMER CONFORMED NAME: SAVE THE WORLD AIR INC DATE OF NAME CHANGE: 20000120 10-Q 1 qs_10q-063019.htm FORM 10-Q

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2019

or

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number 0-29185

 

QS ENERGY, INC.

(Exact name of registrant as specified in its charter)

 

Nevada 52-2088326

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

23902 FM 2978

Tomball, TX 77375

(Address, including zip code, of principal executive offices)

 

(805)-845-3561

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act: None.

 

Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock, $0.001 par value.

 

Check whether the Registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer ☐ Smaller reporting company ☒
  Emerging growth company ☐  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares of the Registrant’s Common Stock outstanding as of August 13, 2019 was 299,149,251.

 

 

 

   

 

 

QS ENERGY, INC.
FORM 10-Q

 

INDEX

 

PART I – FINANCIAL INFORMATION 3
Item 1. Unaudited Condensed Consolidated Financial Statements 3
Condensed Consolidated Balance Sheets 3
Condensed Consolidated Statements of Operations, Unaudited 4
Condensed Consolidated Statement of Stockholders’ Deficit, Unaudited 5
Condensed Consolidated Statements of Cash Flows, Unaudited 7
Notes to Condensed Consolidated Financial Statements, Unaudited 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
Item 3. Quantitative and Qualitative Disclosure about Market Risk 25
Item 4. Controls and Procedures 25
   
PART II – OTHER INFORMATION  
Item 1. Legal Proceedings 27
Item 1A. Risk Factors 27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27
Item 3. Defaults Upon Senior Securities 27
Item 4. Mine Safety Disclosures 27
Item 5. Other Information 27
Item 6. Exhibits 28
   
SIGNATURES 29
   
EXHIBITS 30
EXHIBIT 31.1  
EXHIBIT 31.2  
EXHIBIT 32  

 

 

 

 

 

 

 i 

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Unaudited Condensed Consolidated Financial Statements

 

QS ENERGY, INC.

Condensed Consolidated Balance Sheets

 

   June 30, 2019   December 31, 
   (unaudited)   2018 
ASSETS
Current assets:          
Cash  $711,000   $1,153,000 
Prepaid expenses and other current assets   239,000    34,000 
Total current assets   950,000    1,187,000 
Property and equipment, net of accumulated depreciation of $76,000 and $73,000 at June 30, 2019 and December 31, 2018, respectively   21,000    24,000 
Other assets   2,000    2,000 
Total assets  $973,000   $1,213,000 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable-license agreements  $1,137,000   $1,073,000 
Accounts payable and accrued expenses   505,000    658,000 
Accrued expenses and accounts payable-related parties       55,000 
Convertible debentures, net of discounts of $369,000 and $1,100,000 at June 30, 2019 and December 31, 2018, respectively   855,000    909,000 
Total current liabilities   2,497,000    2,695,000 
           
Commitments and contingencies          
           
Stockholders’ deficit          
Common stock, $.001 par value: 500,000,000 shares authorized, 298,457,191 and 256,123,515 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively   298,456    256,123 
Additional paid-in capital   115,085,544    111,429,877 
Accumulated deficit   (116,908,000)   (113,168,000)
Total stockholders’ deficit   (1,524,000)   (1,482,000)
Total liabilities and stockholders’ deficit  $973,000   $1,213,000 

 

See notes to condensed consolidated financial statements.

 

 

 

 

 3 

 

 

QS ENERGY, INC.

Condensed Consolidated Statements of Operations, Unaudited

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2019   2018   2019   2018 
Revenues  $   $   $   $ 
Costs and Expenses                    
Operating expenses   655,000    462,000    1,133,000    956,000 
Research and development expenses   432,000    48,000    583,000    95,000 
Loss before other expense   (1,087,000)   (510,000)   (1,716,000)   (1,051,000)
Other expense                    
Interest and financing expense   (371,000)   (248,000)   (2,024,000)   (407,000)
Net Loss  $(1,458,000)  $(758,000)  $(3,740,000)  $(1,458,000)
                     
Net loss per common share, basic and diluted  $(0.00)  $(0.00)  $(0.01)  $(0.01)
                     
Weighted average common shares outstanding, basic and diluted   293,284,367    242,994,163    279,658,273    238,825,606 

 

See notes to condensed consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 4 

 

 

QS ENERGY, INC.

Condensed Consolidated Statement of Stockholders’ Deficit, Unaudited

For the SIX months Ended June 30, 2019 and June 30, 2018

 

   Common Stock   Additional
Paid-in
   Accumulated     Total Stockholders’  
   Shares   Amount   Capital   Deficit     Deficit  
Balance, January 1, 2019   256,123,515   $256,123   $111,429,877   $(113,168,000)  $ (1,482,000 )
Common stock issued on exercise of warrants and options   3,677,190    3,677    269,323          $273,000  
Common stock issued on conversion of notes payable   38,406,486    38,406    2,006,594          2,045,000  
Fair value of warrants and beneficial conversion feature of issued convertible notes             1,118,000          1,118,000  
Fair value of options and warrants issued as compensation             194,000          194,000  
Common stock issued for services   250,000    250    67,750          68,000  
Net loss                  (3,740,000)    (3,740,000 )
Balance, June 30, 2019   298,457,191   $298,456   $115,085,544   $(116,908,000)  $ (1,524,000 )

 

 

   Common Stock   Additional
Paid-in
   Accumulated   Total Stockholders’ 
   Shares   Amount   Capital   Deficit   Deficit 
Balance, January 1, 2018   234,076,907   $234,077   $108,000,923   $(110,109,000)  $(1,874,000)
Common stock issued on exercise of warrants and options   12,697,483    12,697    634,303         647,000 
Common stock issued on conversion of notes payable   4,624,125    4,624    332,376         337,000 
Fair value of warrants and beneficial conversion feature of issued convertible notes             319,000         319,000 
Fair value of options and warrants issued as compensation             245,000         245,000 
Common stock issued for services   50,000    50    11,950         12,000 
Net loss                  (1,458,000)   (1,458,000)
Balance, June 30, 2018   251,448,515   $251,448   $109,543,552   $(111,567,000)  $(1,772,000)

 

See notes to condensed consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

 5 

 

 

QS ENERGY, INC.

Condensed Consolidated Statement of Stockholders’ Deficit, Unaudited

For the THREE months Ended June 30, 2019 and June 30, 2018

 

   Common Stock   Additional
Paid-in
   Accumulated     Total Stockholders’  
   Shares   Amount   Capital   Deficit     Deficit  
Balance, April 1, 2019   294,805,488   $294,805   $114,166,195   $(115,450,000)  $ (989,000 )
Common stock issued on exercise of warrants and options   1,715,037    1,715    99,285          $101,000  
Common stock issued on conversion of notes payable   1,686,666    1,686    207,314          209,000  
Fair value of warrants and beneficial conversion feature of issued convertible notes             450,000          450,000  
Fair value of options and warrants issued as compensation             95,000          95,000  
Common stock issued for services   250,000    250    67,750          68,000  
Net loss                  (1,458,000)    (1,458,000 )
Balance, June 30, 2019   298,457,191   $298,456   $115,085,544   $(116,908,000)  $ (1,524,000 )

 

 

   Common Stock   Additional
Paid-in
   Accumulated   Total Stockholders’ 
   Shares   Amount   Capital   Deficit   Deficit 
Balance, April 1, 2018   236,751,367   $236,752   $108,568,248   $(110,809,000)  $(2,004,000)
Common stock issued on exercise of warrants and options   11,351,773    11,351    564,649         576,000 
Common stock issued on conversion of notes payable   3,345,375    3,345    234,655         238,000 
Fair value of warrants and beneficial conversion feature of issued convertible notes             74,000         74,000 
Fair value of options and warrants issued as compensation             102,000         102,000 
Net loss                  (758,000)   (758,000)
Balance, June 30, 2018   251,448,515   $251,448   $109,543,552   $(111,567,000)  $(1,772,000)

 

See notes to condensed consolidated financial statements.

 

 

 

 

 

 

 

 

 6 

 

 

QS ENERGY, INC.

Condensed Consolidated Statements of Cash Flows, Unaudited

 

   Six months ended 
   June 30 
   2019   2018 
Cash flows from Operating Activities          
Net loss  $(3,740,000)  $(1,458,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock based compensation expense   194,000    245,000 
Issuance of common stock for services   68,000    12,000 
Amortization of debt discount and interest expense   1,991,000    381,000 
Depreciation and amortization   3,000    17,000 
Changes in operating assets and liabilities:          
Prepaid expenses and other assets   (205,000)   6,000 
Accounts payable and accrued expenses   (153,000)   (13,000)
Accounts payable – license agreements   64,000    122,000 
Accounts payable and accrued expenses – related parties   (55,000)   12,000 
Deposits and other current liabilities        
Net cash used in operating activities   (1,833,000)   (676,000)
Cash flows from financing activities          
Net proceeds from issuance of convertible notes and warrants   1,118,000    318,000 
Net proceeds from exercise of warrants   273,000    647,000 
Net cash provided by financing activities   1,391,000    965,000 
Net increase (decrease) in cash   (442,000)   289,000 
Cash, beginning of period   1,153,000    204,000 
Cash, end of period  $711,000   $493,000 
           
Supplemental disclosures of cash flow information          
Cash paid during the year for:          
Interest  $   $ 
Income Taxes  $1,600   $1,600 
Non-cash investing and financing activities          
Conversion of convertible debentures to common stock  $2,045,000   $337,000 
Fair value of warrants and beneficial conversion feature associated with issued convertible notes  $1,118,000   $319,000 

 

See notes to condensed consolidated financial statements.

 

 

 

 

 7 

 

 

QS ENERGY, INC.
Notes to Condensed Consolidated Financial Statements, Unaudited

SIX MONTHS ENDED JUNE 30, 2019 AND 2018

 

  1. Description of Business

 

QS Energy, Inc. (“QS Energy”, “Company”) was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc. The Company’s common stock is quoted under the symbol “QSEP” on the Over-the-Counter Bulletin Board. More information including the Company’s fact sheet, logos and media articles are available at our corporate website, www.qsenergy.com.

 

QS Energy develops and commercializes energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions. The Company's intellectual properties include a portfolio of domestic and international patents and patents pending, a substantial portion of which have been developed in conjunction with and exclusively licensed from Temple University of Philadelphia, PA (“Temple”). QS Energy's primary technology is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product. Engineered specifically to reduce pipeline pressure loss, increase pipeline flow rate and capacity, and reduce shippers’ reliance on diluents and drag reducing agents to meet pipeline maximum viscosity requirements, AOT is a 100% solid-state system that reduces crude oil viscosity by applying a high intensity electrical field to crude oil feedstock while in transit. The AOT product is seeking to transition from the research and development stage to initial production for continued testing in advance of our goal of seeking acceptance and adoption by the midstream pipeline marketplace.

 

Basis of Presentation

 

The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the SEC. The condensed consolidated balance sheet as of December 31, 2018 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

 

  2. Summary of Significant Accounting Policies

 

Consolidation Policy

 

The accompanying consolidated financial statements of QS Energy Inc. include the accounts of QS Energy Inc. (the Parent) and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.

 


 

 8 

 

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the six-months ended June 30, 2019, the Company incurred a net loss of $3,740,000, used cash in operations of $1,833,000 and had a stockholders’ deficit of $1,524,000 as of that date. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2018 financial statements, has raised substantial doubt about the Company's ability to continue as a going concern.

 

At June 30, 2019, the Company had cash on hand in the amount of $711,000. Management estimates that the current funds on hand will be sufficient to continue operations through November 2019, or, subject to actual costs incurred implementing design modifications to our AOT demonstration project described in Part I, Item 2, October 2019. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain payments to a former officer and consulting fees, during the remainder of 2019 and beyond.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.

  

Basic and Diluted Income (loss) per share

 

Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an antidilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the Company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. At June 30, 2019 and 2019, we excluded the outstanding securities summarized below, which entitle the holders thereof to acquire shares of common stock as their effect would have been anti-dilutive.

 

 

 

 9 

 

 

   June 30,
2019
   June 30,
2018
 
Options   39,450,603    37,301,300 
Warrants   25,713,204    5,006,355 
Common stock issuable upon conversion of notes payable   12,784,543    5,287,502 
Total   77,948,350    47,595,157 

 

Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.

 

Revenue Recognition Policy

 

Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that supersedes nearly all existing revenue recognition guidance under current U.S. GAAP and replaces it with a principle-based approach or determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.

 

Research and Development Costs

 

Research and development costs are expensed as incurred and consist primarily of fees paid to consultants and outside service providers, and other expenses relating to the acquisition, design, development and testing of the Company’s products. Certain research and development activities are incurred under contract. In those instances, research and development costs are charged to operations ratably over the life of the underlying contracts, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. Payments made pursuant to research and development contracts are initially recorded as advances on research and development contract services in the Company’s consolidated balance sheet and then charged to research and development costs in the Company’s consolidated statement of operations as those contract services are performed.

 

In January 2019, the Company paid $500,000 as a deposit under terms of a work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized $450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019.

 

For the six-month periods ended June 30, 2019 and 2018 research and development costs were $583,000 and $95,000, respectively. For the three-month periods ended June 30, 2019 and 2018 research and development costs were $432,000 and $48,000, respectively.

 

 

 

 10 

 

 

Patent Costs

 

Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT and Joule Heat products, all patent costs are expensed as incurred. During the six-month periods ended June 30, 2019 and 2018, patent costs were $9,000 and $12,000, respectively, which is included as part of operating expenses in the accompanying consolidated statements of operations.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statement presentation or disclosures.

 

  3. Accrued Expenses and Accounts Payable

 

Accrued Expenses

 

As of June 30, 2019 and December 31, 2018, the Company owed $267,000 and $327,000, respectively, pursuant to a separation agreement with a former executive officer effective April 1, 2017 as amended by letter agreements dated effective August 16, 2018 and March 31, 2019 which included as part of Accrued expenses and accounts payable on the accompanying balance sheet. The amount is to be repaid at an amount of $10,000 per month.

 

Accrued Expenses and Accounts Payable – Related Parties

 

Accrued expense – related parties consists of accrued current salaries of officers and fees due to members of the Board of Directors. As of June 30, 2019, and December 31, 2018, accrued expenses and accounts payable to related parties amounted to $0 and $55,000, respectively.

 

  4. Property and Equipment

 

At June 30, 2019 and December 31, 2018, property and equipment consists of the following:

 

   June 30,
2019
   December 31,
2018
 
Office equipment  $30,000   $30,000 
Furniture and fixtures   5,000    5,000 
Testing Equipment   37,000    37,000 
Leasehold Improvements   25,000    25,000 
Subtotal   97,000    97,000 
Less accumulated depreciation   (76,000)   (73,000)
Total  $21,000   $24,000 

 

 

 

 11 

 

 

Depreciation expense for the six-month periods ended June 30, 2019 and 2018 was $3,000 and $17,000, respectively. Depreciation expense for the three-month periods ended June 30, 2019 and 2018 was $1,000 and $9,000, respectively.

  

  5. Convertible Notes

 

  

June 30,
2019

(unaudited)

  

December 31,

2018

 
Balance due on convertible notes  $1,073,000   $1,886,000 
Accrued interest   151,000    123,000 
Subtotal   1,224,000    2,009,000 
Convertible note discount   (369,000)   (1,100,000)
Balance on convertible notes, net of note discounts  $855,000   $909,000 

 

The Company issues convertible notes in exchange for cash. The notes typically do not bear any interest; however, there is an implied interest rate of 10% since the notes are typically issued at a 10% discount. The notes are unsecured, and usually mature twelve months from issuance.

 

The notes are convertible at the option of the note holder into the Company’s common stock at a conversion price stipulated in the conversion agreement. In addition, the note holders receive warrants to purchase shares of common stock that are fully vested and will expire in one year from the date of issuance. As a result, the Company records a note discount to account for the relative fair value of the warrants, the notes’ beneficial conversion feature or BCF, and original issue discount of 10% (OID). The note discounts are amortized over the term of the notes or amortized in full upon its conversion to common stock.

 

As of December 31, 2018, total outstanding notes payable amounted to $1,886,000 which are due through December 2019 and unamortized note discount of $1,100,000.

 

During the six-month period ended June 30, 2019, the Company issued similar convertible promissory notes in the aggregate of $1,230,000 for cash of $1,118,000 or a discount of $112,000. The notes do not bear any interest; however, the implied interest rate used was 10% since the notes were issued 10% less than its face value. The notes are unsecured, mature in twelve months from issuance and convertible at $0.05 to $0.15 per share. In addition, the Company also granted these note holders warrants to purchase 9.0 million shares of the Company’ common stock. The warrants are fully vested, exercisable at $0.05 to $0.15 per share and will expire in one year. As a result, the Company recorded a note discount of $1,118,000 to account for the relative fair value of the warrants, the notes’ beneficial conversion feature (BCF), and original issue discount (OID). The note discounts are being amortized over the term of the note or amortized in full upon the conversion to common stock. During the six-month period ended June 30, 2019 notes payable of $2,045,000 were converted into 38,406,486 shares of common stock.

 

As of June 30, 2019, total outstanding notes payable amounted to $1,073,000, accrued interest of $151,000 and unamortized note discount of $369,000 for a net balance of $855,000. A total of nine notes in the aggregate of $491,000 have reached maturity and are past due.

 

  6. Research and Development

 

The Company constructs, develops and tests the AOT technologies with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as license fees, prototype equipment fabrication and installation, purchase of test equipment, pipeline pumping equipment, crude oil tank batteries, viscometers, SCADA systems, computer equipment, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company’s AOT prototypes.

 

 

 

 12 

 

 

Costs incurred for research and development are expensed as incurred. Purchased materials that do not have an alternative future use are also expensed. Furthermore, costs incurred in the construction of prototypes with no certainty of any alternative future use and established commercial uses are also expensed.

 

For the six-month periods ended June 30, 2019 and 2018, our research and development expenses were $583,000 and $95,000 respectively. For the three-month periods ended June 30, 2019 and 2018, our research and development expenses were $432,000 and $48,000 respectively.

 

AOT Product Development and Testing

 

The Company constructs, develops and tests the AOT technologies with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as prototype equipment fabrication and installation, testing fees, purchase of test equipment, pipeline pumping equipment, crude oil tank batteries, viscometers, SCADA systems, computer equipment, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company’s AOT prototypes.

 

During the six-month periods ended June 30, 2019 and 2018, the Company incurred total expenses of $489,000 and $1,000, respectively, in the manufacture, delivery and testing of the AOT prototype equipment. During the three-month periods ended June 30, 2019 and 2018, the Company incurred total expenses of $384,000 and $1,000, respectively, in the manufacture, delivery and testing of the AOT prototype equipment. Included in this amount, were costs related to a $500,000 work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized $450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019. There were no such expenses for the comparable period in 2018.

 

Temple University Licensing Agreement

 

On August 1, 2011, the Company and Temple University (“Temple”) entered into two (2) Exclusive License Agreements (collectively, the “License Agreements”) relating to Temple’s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the “First Temple License”), and to technology to reduce crude oil viscosity (the “Second Temple License”). The License Agreements are exclusive, and the territory licensed to the Company is worldwide and replace previously issued License Agreements.

 

Pursuant to the two licensing agreements, the Company paid Temple a non-refundable license maintenance fee of $300,000 and agreed to pay (i) annual maintenance fees of $187,500; (ii) royalty fee ranging from 4% up to 7% from revenues generated from the licensing agreements; and (iii) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. The term of the licenses commenced in August 2011 and will expire upon expiration of the patents. The agreements can also be terminated by either party upon notification under terms of the licensing agreements or if the Company ceases the development of the patent or fails to commercialize the patent rights.

 

Total expenses recognized during each six-month periods ended June 30, 2019 and 2018 pursuant to these two License Agreements amounted to $94,000 and $94,000, respectively. Total expenses recognized during each three-month periods ended June 30, 2019 and 2018 pursuant to these two License Agreements amounted to $47,000 and $47,000, respectively. Total expenses have been reflected in Research and Development expenses on the accompanying consolidated statements of operations. In the six-month periods ended June 30, 2019 and 2018, the Company also recognized penalty interest on past-due balances of $33,000 and $26,000, respectively, which is included as part of interest and financing expense in the accompanying statements of operations.

 

 

 

 13 

 

 

As of June 30, 2019 and December 31, 2018, total unpaid fees due to Temple pursuant to these agreements are $1,137,000 and $1,073,000, respectively, which are included as part of Accounts Payable – license agreements in the accompanying consolidated balance sheets. With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $1,002,000 are deemed past due. The Company is currently in negotiations with Temple to settle or cure the past due balance.

 

No revenues were earned from the two License Agreements during the six-month periods ended June 30, 2019 and June 30, 2018.

 

  7. Common Stock

 

During the six months ended June 30, 2019, the Company issued 42,333,676 shares of its common stock as follows:

 

  · The Company issued 38,406,486 shares of its common stock upon the conversion of $2,045,000 in convertible notes pursuant to the convertible notes conversion prices of $0.05 to $0.15 per share.

 

  · The Company issued 3,138,993 shares of its common stock upon the exercise of warrants for proceeds of $202,000 at exercise prices of $0.05 to $0.18 per share.

 

  · The Company issued 538,197 shares of its common stock upon the exercise of options for proceeds of $71,000 at exercise prices of $0.08 to $0.18 per share.

  

  · The Company issued 250,000 shares of its common stock in exchange for $68,000 for services valued at $0.27 per share.

 

  8. Stock Options and Warrants

 

The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. Options vest and expire according to terms established at the grant date.

 

Options

 

Options vest according to the terms of the specific grant and expire from 2 to 10 years from date of grant. The weighted-average, remaining contractual life of employee and non-employee options outstanding at June 30, 2019 was 5.2 years. Stock option activity for the period January 1, 2019 up to June 30, 2019, was as follows:

 

    Options   Weighted
Avg. Exercise
Price
 
January 1, 2019    35,301,300   $0.22 
Granted    4,687,500    0.08 
Exercised    (538,197)   0.13 
Forfeited         
June 30, 2019    39,450,603   $0.20 

  

 

 

 14 

 

 

The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest as of June 30, 2019 were as follows:

 

     Outstanding Options    Exercisable Options 
Option
Exercise Price
Per Share
    Shares    Life
(Years)
    Weighted
Average Exercise
Price
    Shares    Weighted
Average Exercise
Price
 
$0.05 - $0.24     17,915,553    8.0   $0.10    15,702,013   $0.10 
$0.25 - $0.49     20,913,552    2.8    0.27    20,913,552    0.27 
$0.50 - $0.99     471,052    4.8    0.85    471,052    0.85 
$1.00 - $2.00     150,446    4.1    1.18    150,446    1.18 
     39,450,603    5.2   $0.20    37,237,063   $0.21 

 

During the six-month period ending June 30, 2019, and pursuant to the Company’s Board Compensation policy approved by the Board June 19, 2015, the Company granted options to purchase 4,687,500 shares of common stock to members of the Company’s Board of Directors. The options are exercisable at $0.08 share, vest monthly over a twelve-month period, and expire ten years from the date granted. Total fair value of these options at grant date was $328,000 using the Black-Scholes Option Pricing model with the following assumptions: life of 5 years; risk free interest rate of 2.5%; volatility of 122% and dividend yield of 0%.

 

During the six-month periods ended June 30, 2019 and 2018, the Company recognized compensation costs based on the fair value of options that vested of $183,000 and $535,000 respectively. During the three-month periods ended June 30, 2019 and 2018, the Company recognized compensation costs based on the fair value of options that vested of $85,000 and $102,000 respectively.

 

At June 30, 2019, the Company’s closing stock price was $0.24 per share. The aggregate intrinsic value of the options outstanding at June 30, 2019 was $2,553,000. Future unamortized compensation expense on the unvested outstanding options at June 30, 2019 is approximately $164,000 to be recognized through December 2019.

 

Warrants

 

The following table summarizes certain information about the Company’s stock purchase warrants activity for the period starting January 1, 2019 up to June 30, 2019.

 

    Warrants   Weighted Avg.
Exercise Price
 
January 1, 2019    21,055,355   $0.09 
Granted    9,099,204    0.08 
Exercised    (3,138,993)   0.07 
Cancelled    (1,302,362)   0.19 
June 30, 2019    25,713,204   $0.08 

 

 

 

 15 

 

 

The weighted average exercise prices, remaining contractual lives for warrants granted, exercisable, and expected to vest as of June 30, 2019 were as follows:

 

     Outstanding Warrants    Exercisable Warrants  
Warrant Exercise Price Per Share    Shares    Life
(Years)
    Weighted
Average Exercise Price
    Shares    Weighted
Average Exercise Price
 
$0.05 - $0.24    23,643,204    0.6   $0.06    23,577,204   $0.06  
$0.25 - $0.49    2,000,000    2.3    0.30    2,000,000    0.30  
$0.50 - $1.00    70,000    4.8    0.80    70,000    0.80  
     25,713,204    0.7   $0.08    25,647,204   $0.08  

 

In the six-month period ending June 30, 2019, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 8,999,205 shares of common stock with an exercise price of $.05 to $0.18 per share, vesting immediately upon grant and expiring one year from the date of grant (see Note 5, above).

 

In the six-month period ending June 30, 2019, the Company issued warrants to purchase 99,999 shares of common stock with an exercise price of $0.24 per share, vesting over three months and expiring two years from the date of grant as compensation under an independent consulting agreement. Total fair value of the warrants at grant date was $17,000 using the Black-Scholes model with the following assumptions: life of 2.3 years; risk free interest rate of 1.75%; volatility of 153% and dividend yield of 0%.

 

During the six-month period ended June 30, 2019, warrants to acquire 3,138,993 shares of common stock were exercised resulting in net proceeds to the Company of $202,000.

 

At June 30, 2019, the aggregate intrinsic value of the warrants outstanding was $4,231,000.

 

  9. Commitments and Contingencies

 

There is no current or pending litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.

 

  10. Subsequent Events

 

Conversion of Convertible Notes

 

From July 1, 2019 up to August 13, 2019, Company issued 329,560 shares of common stock upon conversion of previously issued convertible notes in aggregate value of $50,000.

 

Exercise of Warrants

 

From July 1, 2019 up to August 13, 2019, Company issued 362,500 shares of common stock upon the exercise of previously issued warrants for aggregate cash proceeds of $19,000.

 

 

 

 

 

 16 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Consolidated Financial Statements and supplementary data referred to in this Form 10-Q.

 

This discussion contains forward-looking statements that involve risks and uncertainties. Such statements, which include statements concerning future revenue sources and concentration, selling, general and administrative expenses, research and development expenses, capital resources, additional financings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed elsewhere in this Form 10-Q, and in the “Risk Factors” section filed with the SEC on April 1, 2019, that could cause actual results to differ materially from those projected. Unless otherwise expressly indicated, the information set forth in this Form 10-Q is as of June 30, 2019, and we undertake no duty to update this information.

 

Overview

 

QS Energy, Inc. (“QS Energy” or “Company” or “we” or “us” or “our”) develops and commercializes energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil transport, and reducing greenhouse gas emissions. The Company's intellectual properties include a portfolio of domestic and international patents and patents pending, a substantial portion of which have been developed in conjunction with and exclusively licensed from Temple University of Philadelphia, PA (“Temple”). QS Energy's primary technology is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product. Engineered specifically to reduce pipeline pressure loss, increase pipeline flow rate and capacity, and reduce shippers’ reliance on diluents and drag reducing agents to meet pipeline maximum viscosity requirements, AOT is a 100% solid-state system that reduces crude oil viscosity by applying a high intensity electrical field to crude oil while in transit. AOT technology delivers reductions in crude oil viscosity and pipeline pressure loss as demonstrated in independent third-party tests performed by the U.S. Department of Energy, the PetroChina Pipeline R&D Center, and ATS RheoSystems, a division of CANNON™, at full-scale test facilities in the U.S. and China, and under commercial operating conditions on one of North America’s largest high-volume crude oil pipelines. Prior testing on a commercial crude oil condensate pipeline demonstrated high correlation between laboratory analysis and full-scale AOT operations under commercial operating conditions with onsite measurements and data collected by the pipeline operator on its supervisory control and data acquisition (“SCADA”) system. The AOT product has transitioned from laboratory testing and ongoing research and development to initial production and continued testing in advance of our goal of seeking commercial acceptance and adoption by the upstream and midstream pipeline marketplace. We continue to devote the bulk of our efforts to the promotion, design, testing and the commercial manufacturing and operations of our crude oil pipeline products in the upstream and midstream energy sector. We anticipate that these efforts will continue during 2019.

 

Our Company was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc. The name change was affected through a short-form merger pursuant to Section 92A.180 of the Nevada Revised Statutes. Additionally, QS Energy Pool, Inc., a California corporation, was formed as a wholly-owned subsidiary of the Company on July 6, 2015 to serve as a vehicle for the Company to explore, review and consider acquisition opportunities. To date, QS Energy Pool has not entered into any acquisition transaction. However, the Company will still consider entering into potential beneficial acquisitions. The Company is considering dissolving QS Energy Pool to reduce costs associated with operating this subsidiary. The Company’s common stock is quoted under the symbol “QSEP” on the Over-the-Counter Bulletin Board. More information including the Company’s fact sheet, logos and media articles are available at our corporate website, www.qsenergy.com.

 

Between 2011 and 2012, the Company transitioned from prototype testing of its AOT technology at the U.S. Department of Energy Rocky Mountain Oilfield Testing Center, Midwest, Wyoming (“RMOTC”), to the design and production of full-scale commercial prototype units. The Company worked in a collaborative engineering environment with multiple energy industry companies to refine the AOT Midstream commercial design to comply with the stringent standards and qualification processes as dictated by independent engineering audit groups and North American industry regulatory bodies. In May 2013, the Company’s first commercial prototype unit known as AOT Midstream, was completed.

 

 

 

 17 

 

 

In 2013, the Company entered into an Equipment Lease/Option to Purchase Agreement (“TransCanada Lease”) with TransCanada Keystone Pipeline, L.P. by its agent TC Oil Pipeline Operations, Inc. ("TransCanada") which agreed to lease and test the effectiveness of the Company’s AOT technology and equipment on one of TransCanada’s operating pipelines. As previously reported in our 10-K report filed with the SEC on March 16, 2015, in June 2014, the equipment was accepted by TransCanada and the lease commenced and the first full test of the AOT equipment on the Keystone pipeline was performed in July 2014 by Dr. Rongjia Tao of Temple University, with subsequent testing performed by an independent laboratory, ATS RheoSystems, a division of CANNON™ (“ATS”) in September 2014. Upon review of the July 2014 test results and preliminary report by Dr. Tao, QS Energy and TransCanada mutually agreed that this initial test was flawed due to, among other factors, the short-term nature of the test, the inability to isolate certain independent pipeline operating factors such as fluctuations in upstream pump station pressures, and limitations of the AOT device to produce a sufficient electric field to optimize viscosity reduction. Subsequent testing by ATS in September 2014 demonstrated viscosity reductions of 8% to 23% depending on flow rates and crude oil types in transit. In its summary report, ATS concluded that i) data indicated a decrease in viscosity of crude oil flowing through the TransCanada pipeline due to AOT treatment of the crude oil; and ii) the power supply installed on our equipment would need to be increased to maximize reduction in viscosity and take full advantage of the AOT technology. While more testing is required to establish the commercial efficacy of our AOT technology, we are encouraged by the findings of these field tests performed under commercial operating conditions. The TransCanada Lease was terminated by TransCanada, effective October 15, 2014. Upon termination of the TransCanada Lease, all equipment was uninstalled, returned, inspected and configured for re-deployment.

 

On July 15, 2014, the Company entered into an Equipment Lease/Option to Purchase Agreement (“Kinder Morgan Lease”) with Kinder Morgan Crude & Condensate, LLC (“Kinder Morgan”) under which Kinder Morgan agreed to lease and test the effectiveness of the Company’s AOT technology and equipment on one of Kinder Morgan’s operating crude oil condensate pipelines. Equipment provided under the Lease includes a single AOT Midstream pressure vessel with a maximum flow capacity of 5,000 gallons per minute. The equipment was delivered to Kinder Morgan in December 2014 and installed in March 2015. In April 2015, during pre-start testing, low electrical impedance was measured in the unit, indicating an electrical short. A replacement unit was installed May 2015. The second unit also presented with low impedance when flooded with crude condensate from Kinder Morgan’s pipeline. Subsequent to design modifications, a remanufactured AOT unit was installed and tested at Kinder Morgan’s pipeline facility in August 2015. Initial results were promising, with the unit operating generally as expected. However, voltage dropped as preliminary tests continued, indicating decreased impedance within the AOT pressure vessel. QS Energy personnel and outside consultants performed a series of troubleshooting assessments and determined that, despite modifications made to the AOT, conductive materials present in the crude oil condensate appeared to be the root cause of the decreased impedance. Based on these results, QS Energy and Kinder Morgan personnel mutually agreed to put a hold on final acceptance of equipment under the lease and suspended in-field testing to provide time to re-test crude oil condensate in a laboratory setting, and thoroughly review and test selected AOT component design and fabrication. Subsequent analysis and testing led to changes in electrical insulation, inlet flow improvements and other component modifications. These design changes were implemented and tested by Industrial Screen and Maintenance (ISM), one of QS Energy's supply chain partners in Casper, Wyoming. Tests performed by ISM at its Wyoming facility indicated significant improvements to system impedance and efficiency of electric field generation.

 

In February 2016, the modified AOT equipment was installed at Kinder Morgan’s facility. Pre-acceptance testing was performed in April 2016, culminating in more than 24 hours of continuous operations. In-field viscosity measurements and pipeline data collected during this test indicated the AOT equipment operated as expected, demonstrating viscosity reductions equivalent to those measured under laboratory conditions. Supervisory Control And Data Acquisition (“SCADA”) pipeline operating data collected by Kinder Morgan during this test indicated a pipeline pressure drop reduction consistent with expectations. Results of this test were promising, however due to the short duration of the test and limited data collection, definitive conclusions regarding the AOT performance and its impact on pipeline operations could not be reached. Based on final analysis of in-field test results, SCADA operating data and subsequent analysis of crude oil condensate samples at Temple University, it is unlikely Kinder Morgan would use the AOT at the original test location or other condensate pipeline. Kinder Morgan has expressed interest in AOT operations at one of their heavy crude pipeline locations subject to results of other AOT demonstration projects and has provided the Company with additional crude oil samples which have been tested at Temple University for future test correlation and operational planning purposes. The Kinder Morgan Lease is currently in suspension and lease payments have not yet commenced.

  

 

 

 18 

 

 

Southern Research Institute (SRI) was engaged by QS Energy in 2015 to investigate the root cause of the crude oil condensate impedance issue by replicating conditions experienced in the field utilizing a laboratory-scaled version of the AOT and crude oil condensate samples provided by Kinder Morgan. In addition, QS Energy retained an industry expert petroleum pipeline engineer to review the AOT design and suggest design modifications to resolve the crude oil condensate impedance issue. This engineer has studied design details, staff reports and forensic photographs of each relevant AOT installation and test. Based on these investigations, specific modifications were proposed to resolve the impedance issue, and improve the overall efficiency of the AOT device, resulting in a new value-engineered design of certain AOT internal components.

 

During the third quarter 2016, the Company developed an onsite testing program to demonstrate AOT viscosity reduction at prospective customer sites. This program utilized a laboratory-scale AOT device designed and developed by the Company and tested at the Southern Research Institute. Under this program, Company engineers set up a temporary lab at the customer’s site to test a full range of crude oils. Fees charged for providing this service were dependent on scope of services, crude oil sample to be tested, and onsite time requirements. In the fourth quarter 2016, the Company entered a contract to provide these onsite testing services to a North American oil producer and pipeline operator over a one-week period in early 2017 at a fixed price of $50,000. This test was performed in January 2017; data analysis and final report was completed in March 2017. Test results demonstrated viscosity reduction under limited laboratory conditions. The oil producer has since requested access to observe a full-scale demonstration facility and view operating data when they become available.

 

In 2014, the Company began development of a new suite of products based around the new electrical heat system which reduces oil viscosity through a process known as joule heat (“Joule Heat”). The Company built and tested its first Joule Heat prototype in June 2015. The system was operational; however, changes to the prototype configuration will be required to determine commercial effectiveness of this unit. In December 2015, we suspended Joule Heat development activities to focus Company resources on finalizing commercial development of the AOT. We plan to resume Joule Heat development in the future depending on the availability of sufficient capital and other resources.

 

In July 2017, the Company filed for trademark protection for the word “eDiluent” in advance of rolling out a new marketing and revenue strategy based on the concept of using AOT to reduce pipeline dependence upon diluent to reduce viscosity of crude oils. A primary function of AOT is to reduce viscosity by means of its solid-state electronics technology, in essence providing an electronic form of diluent, or “eDiluent”. The Company plans to market and sell a value-added service under the name eDiluent, designed to be upsold by the Company’s midstream pipeline customers in an effort to provide the Company with long-term recurring revenues.

 

During the third quarter 2017, the Company built a dedicated laboratory space at its Tomball Texas facility, and now has the capability to perform onsite testing utilizing our laboratory-scale AOT device, among other equipment. Development of an AOT unit for use in crude oil upstream and gathering operations was restarted in September 2017 utilizing resources at the Tomball facility, and the Company plans to resume Joule Heat development in the future depending on the availability of sufficient capital and other resources. Also, during the third quarter 2017, the Company built an outdoor facility at its Tomball Texas facility for onsite storage of AOT inventory and other large equipment. The Tomball facility is owned by the Company’s CEO as described in our Form 10-K filed with the SEC on April 1, 2019.

 

Throughout 2018 our primary strategic goal was focused on installing and operating a demonstration AOT project on a commercial crude oil pipeline. Much of our time was spent meeting with industry executives and engineers in North and South America and working with local representatives in the Asian and the Middle Eastern markets. In December 2018, we reached mutual agreement with a major U.S.-based pipeline operator on a demonstration project under which we will install and operate our AOT equipment on a crude oil pipeline located in the Southern United States in 2019. We believe the selected project site should be ideal for demonstration purposes, delivering heavy crudes which, based on samples tested at Temple University, and, subject to the discussion below, should experience significant viscosity reduction when treated with our AOT technology.

 

 

 

 19 

 

 

While management focused on finding a partner and finalizing terms of the demonstration project, and in our continuing efforts to commercialize our AOT technology, our engineering team worked throughout 2018 to prepare one of our inventoried AOT units for deployment. All system upgrade, inspections and testing protocols were completed in December 2018. The pipeline operator finalized site selection and began site design and engineering in January 2019, completing site preparation and equipment installation in June 2019. The project was installed within budget, quality compliant, and without safety incidents. The system passed the pre-start safety review, data acquisition signal verifications, and mechanical inspections. Under full crude oil flow, the system was confirmed to have no leaks and no environmental issues were noted. Data collected during the full-flow startup phase confirmed internal differential pressures to be negligible and consistent with design specifications. However, when the system was energized, and the unit was run-up to high-voltage operations, the primary power supply began to operate erratically and had to be taken offline. Subsequent inspection determined the primary power supply had failed.

 

After removing the primary power supply, our engineers reconfigured the system to run off a smaller secondary power supply. Although this unit was not capable of achieving target treatment voltage, we performed limited testing and troubleshooting measures, after which the damaged power supply was shipped to the manufacturer for expedited repair and reconditioning; a process expected to take approximately 4-6 weeks. Inspections performed during the repair process indicated internal components had been physically damaged. Though not definitive, it appears that damage may have occurred during transit prior to initial installation at the demonstration site. Repairs were completed in early August 2019 and have been shipped to the site for installation.

 

While the demonstration project was offline for power supply repairs, our engineering team worked with oil samples pulled from the operating pipeline for testing at our Tomball laboratory facility. These tests were designed to confirm our target power requirements as accurately as possible and help us fine-tune enhancements planned for a new optimized AOT internal grid pack design we plan to test at the demonstration site as part of our continuing value engineering effort.

 

During initial testing with the small power supply current draw was greater than prior field deployments. While it was expected that the small power supply would not achieve treatment voltage, as voltage was increased, actual current draw experienced under test conditions exceeded the operating limit of the power supply. This was an unexpected result. Initial concerns were the potential for current leakage inside the AOT and water in in the treatment cell of the AOT.

 

We performed an engineering review of drawings to look for possible leakage pathways, but none were indicated. We conducted electrical testing and could not find any shorts from the anode to the chassis or to the cathode. With this, and other tests performed onsite, we believe the unit does not have an electrical issue.

 

After the AOT passed all testing, unit was put online with full crude oil flow established. The constant flow of oil would allow any water that may have accumulated in the AOT to be flushed out of the system. Oil samples were also obtained for testing at the Company’s laboratory in Tomball, Texas.

 

Subsequent laboratory testing performed at our Tomball facility showed the electrical conductivity of the oil to be quite high and in line with field observations. This is further indication that the unit is likely functioning properly and does not have a current leak. It was decided to return to the field and test the AOT and obtain new samples for lab testing to verify previous results. During the field test we were able to verify the high conductivity. We believe this eliminated the possibility the original result was due to water in the cell. We are continuing to test new samples in the lab, but all tests performed to-date indicate high conductivity.

 

Repairs to the power supply were completed in early August 2019. We plan to install the repaired power supply and test the AOT unit at higher power in August 2019; however, based on recent laboratory tests, we expect conductivity of the crude oil to inhibit the AOT’s ability to reach sufficient voltage to fully treat the crude oil. We are also working with the power supply vendor to assess power supply configurations to increase the power output and to match a new power supply to the design of a new grid pack and the target oil. We are also working on modifications to the internal configuration of the AOT grid pack to reduce power requirements when treating highly conductive crude oil. Once we complete the next round of full-scale testing at the demonstration site, we will determine if modifications are required. Our next course of action will be determined at that time.  Based on current plans, required modifications, if any, should be installed and ready for testing in the fourth quarter of 2019.

 

 

 

 20 

 

 

Once the corrective actions discussed above are achieved, our plans moving forward are centered on achieving commercial adoption of our AOT device. Over the past year, we have met with many industry executives who expressed interest in AOT subject to seeing and evaluating commercial operations and data. Assuming successful operations, we believe the demonstration AOT project should provide data requested such as real-time changes in viscosity, pipeline pressure drop reduction and increases in pipeline operating flowrates. All collected data will be normalized such that it can be used to evaluate the financial and operational benefits across a wide range of commercial operating scenarios without disclosing confidential details of our demonstration partner’s operations. We believe that real-world data from our demonstration AOT project may be used to accelerate our desire to achieve commercial adoption of our AOT technology, positioning us to re-engage with industry executives, targeting sales in 2020.

 

The Company is currently pursuing AOT testing in several countries in South America related to upstream, midstream, barge, and tanker truck applications. Oil samples from multiple clients have been shipped from South America for testing at Temple University. There is a vast amount of heavy oil in these countries and we believe the Ministers of Hydrocarbons have standing orders to increase production and transportation capacity. We are also in discussions with an exploration and production company regarding AOT operations on a West Coast heavy crude gathering line that relies heavily on diluent to achieve required viscosity. This project could be designed to demonstrate AOT for upstream and trucking applications. We continued work with an existing client in Asia on a potential AOT demonstration project; however, progress on this project slowed from our original targets. In August 2018, we were informed by our Asian client the project would be suspended and reassessed in 2019 subject to budget and project approval requirements imposed by new management. In August 2018, we were approached by a prospective customer with operations in Russia and other regions in the former Soviet Union with expressed interest in receiving a proposal to install AOTs on a new 2,000 km pipeline. We are maintaining communications with energy companies in Europe and the Middle East as we seek to finalize AOT demonstration project operations. Our ability to do business in some of these and other potential target markets, specifically including Russia, China and Venezuela are now, or may in be future become, restricted or impacted by sanctions, tariffs and other government actions imposed by the United States or foreign governments.

 

Our expenses to date have been funded through the sale of shares of common stock and convertible debt, as well as proceeds from the exercise of stock purchase warrants and options. We will need to raise substantial additional capital through 2019, and beyond, to fund our sales and marketing efforts, continuing research and development, and certain other expenses, until we are able to achieve a revenue base.

 

There are significant risks associated with our business, our Company and our stock. See Part II Item 1A, “Risk Factors,” below.

 

I. Six months ended June 30, 2019 and 2018

 

Results of Operations for six months ended June 30, 2019 and 2018

 

   Six months ended 
   June 30, 
   2019   2018   Change 
Revenues  $   $   $ 
Costs and Expenses               
Operating expenses   1,133,000    956,000    177,000 
Research and development expenses   583,000    95,000    488,000 
Loss before other income (expense)   (1,716,000)   (1,015,000)   (665,000)
Other income (expense)               
Interest and financing expense   (2,024,000)   (407,000)   (1,617,000)
Net Loss  $(3,740,000)  $(1,458,000)  $(2,282,000)

 

 

 

 21 

 

 

Operating expenses were $1,133,000 for the six-month period ended June 30, 2019, compared to $956,000 for the six-month period ended June 30, 2018, an increase of $177,000. This is due to a decrease in non-cash expenses of $10,000 and an increase in cash expenses of $187,000. Specifically, the decrease in non-cash expenses is attributable to decreases in depreciation of $14,000, and stock compensation expense attributable to options granted to employees and directors of $62,000, offset by an increase in common stock and warrants issued as compensation for services of $66,000. The increase in cash expense is attributable increases in consulting fees of $18,000, freight costs of $4,000, insurance of $20,000, office expenses of $33,000, legal and accounting of $6,000, public and investor relations of $65,000, rent and utilities of $11,000, travel expenses of $36,000, and other expenses of $10,000, offset by a decrease in salaries and benefits of $16,000.

 

Research and development expenses were $583,000 for the six-month period ended June 30, 2019, compared to $95,000 for the six-month period ended June 30, 2018, an increase of $488,000. This increase is attributable an increase in prototype product development costs of $488,000.

 

Other income and expense were $2,024,000 expense for the six-month period ended June 30, 2019, compared to $407,000 expense for the three-month period ended June 30, 2018, a net increase in other expenses of $1,617,000. This increase is attributable to an increase in non-cash other expenses of $1,617,000. The increase in non-cash other expense is due to increases in expense attributable to interest, beneficial conversion factors and warrants associated with convertible notes issued in the amount of $1,612,000, and other non-cash interest of $5,000.

 

The Company had a net loss of $3,740,000, or $0.01 per share, for the six-month period ended June 30, 2019, compared to a net loss of $1,458,000, or $0.01 per share, for the six-month period ended June 30, 2018.

 

II. Three months ended June 30, 2019 and 2018

 

   Three months ended 
   June 30 
   2019   2018   Change 
Revenues  $   $   $ 
Costs and expenses               
Operating expenses   655,000    462,000    193,000 
Research and development expenses   432,000    48,000    384,000 
Loss before other income (expense)   (1,087,000)   (510,000)   (577,000)
Other income (expense)               
Interest and financing expense   (371,000)   (248,000)   (123,000)
Net Loss  $(1,458,000)  $(758,000)  $(700,000)

 

The Company had no revenues in the three month-periods ended June 30, 2019 and 2018.

 

Operating expenses were $655,000 for the three-month period ended June 30, 2019, compared to $462,000 for the three-month period ended June 30, 2018, an increase of $193,000. This is due to an increase in non-cash expenses of $54,000, and an increase in cash expenses of $139,000. Specifically, the increase in non-cash expenses is attributable to decreases in depreciation of $7,000, and in stock compensation expenses attributable to the fair value of options granted to directors and employees of $17,000, offset by an increase in common stock and warrants issued as compensation for services of $78,060. The increase in cash expense is attributable increases in consulting fees of $18,000, freight costs of $2,000, insurance of $11,000, office expenses of $19,000, legal and accounting of $16,000, public and investor relations of $44,000, rent and utilities of $11,000, travel expenses of $34,000, and other expenses of $2,000, offset by a decrease in salaries and benefits of $18,000.

 

 

 

 22 

 

 

Research and development expenses were $432,000 for the three-month period ended June 30, 2019, compared to $48,000 for the three-month period ended June 30, 2018, an increase of $383,000. This decrease is attributable to decreases in prototype product development costs of $383,000.

 

Other income and expense were $371,000 expense for the three-month period ended June 30, 2019, compared to $248,000 expense for the three-month period ended June 30, 2018, a net increase in other expenses of $123,000. This increase is attributable to an increase in non-cash other expenses of $123,000. The increase in non-cash other expense is due to an increase in expense attributable to interest, beneficial conversion factors and warrants associated with convertible notes issued in the amount of $123,000.

 

The Company had a net loss of $1,458,000, or $0.00 per share, for the three-month period ended June 30, 2019, compared to a net loss of $758,000, or $0.00 per share, for the three-month period ended June 30, 2018.

 

Liquidity and Capital Resources

 

General

 

As reflected in the accompanying condensed consolidated financial statements, the Company has not yet generated significant revenues and has incurred recurring net losses. We have incurred negative cash flow from operations since our inception in 1998 and a stockholders’ deficit of $1,524,000 as of June 30, 2019. Our negative operating cash flow for the periods ended June 30, 2019 was funded primarily through issuance of convertible notes and execution of options and warrants to purchase common stock.

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements, the Company had a net loss of $3,740,000 and a negative cash flow from operations of $1,833,000 for the six-month period ended June 30, 2019. These factors raise substantial doubt about our ability to continue as a going concern.

 

In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2018 financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to raise additional funds and implement our business plan. The consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

 

Summary

 

During the period ended June 30, 2019, we received cash totaling $1,118,000 from issuance of our convertible notes payable and exercise of options and warrants to purchase common stock and used cash in operations of $273,000. At June 30, 2019, we had cash on hand in the amount of $711,000. We will need additional funds to operate our business, including without limitation the expenses we will incur in connection with the license agreements with Temple University; costs associated with product development and commercialization of the AOT and related technologies; costs to manufacture and ship our products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed above, we have substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain severance payments to a former officer and consulting fees, during the remainder of 2019 and beyond.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company.

 

 

 

 23 

 

 

Licensing Fees to Temple University

 

For details of the licensing agreements with Temple University, see Financial Statements attached hereto, Note 6 (Research and Development).

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosure of contingent assets and liabilities. We evaluate, on an on-going basis, our estimates and judgments, including those related to the useful life of the assets. We base our estimates on historical experience and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

 

The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results that we report in our consolidated financial statements. The SEC considers an entity’s most critical accounting policies to be those policies that are both most important to the portrayal of a company’s financial condition and results of operations and those that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about matters that are inherently uncertain at the time of estimation. For a more detailed discussion of the accounting policies of the Company, see Note 1 of the Notes to the Condensed Consolidated Financial Statements, “Summary of Significant Accounting Policies”.

 

We believe the following critical accounting policies, among others, require significant judgments and estimates used in the preparation of our consolidated financial statements.

 

Estimates

 

The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Certain significant estimates were made in connection with preparing our consolidated financial statements as described in Note 1 to Notes to the Condensed Consolidated Financial Statements. Actual results could differ from those estimates.

  

Stock-Based Compensation

 

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

 

 

 24 

 

 

The fair value of the Company's common stock option grants is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model, and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the six-months ended June 30, 2019, the Company incurred a net loss of $3,740,000, used cash in operations of $1,833,000 and had a stockholders’ deficit of $1,524,000 as of that date. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

At June 30, 2019, the Company had cash on hand in the amount of $711,000. Management estimates that the current funds on hand will be sufficient to continue operations through November 2019, or, subject to actual costs incurred implementing design modifications to our AOT demonstration project described in Part I, Item 2, October 2019. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain payments to a former officer and consulting fees, during the remainder of 2019 and beyond.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.

 

Recent Accounting Polices

 

See Footnote 2 in the accompanying financial statements for a discussion of recent accounting policies.

  

Item 3. Quantitative and Qualitative Disclosure about Market Risk

 

We issue from time to time fixed rate discounted convertible notes. Our convertible notes and our equity securities are exposed to risk as set forth below, in Part II Item 1A, “Risk Factors.” Please also see Item 2, above, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

 

 

 25 

 

 

Item 4. Controls and Procedures

 

  1. Disclosure Controls and Procedures

 

The Company's management, with the participation of the Company's chief executive officer and chief financial officer, evaluated, as of June 30, 2019, the effectiveness of the Company's disclosure controls and procedures, which were designed to be effective at the reasonable assurance level. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of the Company's disclosure controls and procedures as of June 30, 2019, management, the chief executive officer and the chief financial officer concluded that the Company's disclosure controls and procedures were effective at the reasonable assurance level at that date.

 

(a)       Changes in Internal Control over Financial Reporting

 

No change in the Company's internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the six-month period ended June 30, 2019 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 26 

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

There is no litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.

 

Item 1A. Risk Factors

 

There have been no material changes in the risk factors previously disclosed in Form 10-K for the period ended December 31, 2018, which we filed with the SEC on April 1, 2019.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Issuances

 

In private offerings exempt from registration, during the six months ended June 30, 2019, the Company issued 38,406,486 shares of its common stock upon the conversion of $2,045,000 in convertible notes at $0.05 to $0.15 per share. In connection with the issuances of the foregoing securities, the Company relied on the exemption, among other exemptions, from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering.

 

The proceeds received by the Company in connection with the above issuances of shares were used and continue to be used for general corporate purposes including without limitation the demonstration project described in Part I, Item 2.

 

Item 3. Defaults Upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

None

 

Item 5. Other Information

 

None

 

 

 

 

 

 

 

 27 

 

 

Item 6. Exhibits

 

Exhibit No.   Description
     
31.1   Certification of Chief Executive Officer of Quarterly Report Pursuant to Rule 13(a)-15(e) or Rule 15(d)-15(e)
     
31.2   Certification of Chief Financial Officer of Quarterly Report pursuant to Rule 13(a)-15(e) or Rule 15(d)-15(e)
     
32   Certification of Chief Executive Officer and Chief Financial Officer of Quarterly Report Pursuant to 18 U.S.C.  Section 1350
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Schema Document
     
101.CAL   XBRL Calculation Linkbase Document
     
101.LAB   XBRL Label Linkbase Document
     
101.PRE   XBRL Presentation Linkbase Document
     
101.DEF   XBRL Definition Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 28 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  QS ENERGY, INC.  
     
       
Date: August 14, 2019 By: /s/ Michael McMullen  
    Michael McMullen  
    Chief Financial Officer  
       

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 29 

 

 

EXHIBITS

 

Exhibit No.   Description
     
31.1   Certification of Chief Executive Officer of Quarterly Report Pursuant to Rule 13(a)-15(e) or Rule 15(d)-15(e)
     
31.2   Certification of Chief Financial Officer of Quarterly Report Pursuant to Rule 13(a)-15(e) or Rule 15(d)-15(e)
     
32   Certification of Chief Executive Officer and Chief Financial Officer of Quarterly Report Pursuant to 18 U.S.C. Section 1350
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Schema Document
     
101.CAL   XBRL Calculation Linkbase Document
     
101.LAB   XBRL Label Linkbase Document
     
101.PRE   XBRL Presentation Linkbase Document
     
101.DEF   XBRL Definition Linkbase Document 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 30 

 

EX-31.1 2 qs_ex3101.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

AND RULES 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Jason Lane, certify that:

 

1.     I have reviewed this Quarterly Report on Form 10-Q of QS Energy, Inc.;

 

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.     The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) or 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(d)-15(f) for the registrant and have:

 

(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2019 /s/ Jason Lane  
Jason Lane  
Chief Executive Officer  

EX-31.2 3 qs_ex3102.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

AND RULES 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Michael McMullen, certify that:

 

1.     I have reviewed this Quarterly Report on Form 10-Q of QS Energy, Inc.; 

 

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.     The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) or 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(d)-15(f) for the registrant and have:

 

(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2019 /s/ Michael McMullen  
Michael McMullen  
Chief Financial Officer   

EX-32 4 qs_ex3200.htm CERTIFICATION OF PERIODIC FINANCIAL REPORT BY THE CHIEF EXECUTIVE

EXHIBIT 32

 

CERTIFICATION OF PERIODIC FINANCIAL REPORT BY THE CHIEF EXECUTIVE

OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Solely for the purposes of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Acting Chief Executive Officer and the Chief Financial Officer of QS Energy, Inc. (the “Company”), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2019 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: August 14, 2019 /s/ Jason Lane
Jason Lane
Chief Executive Officer 
 
Date: August 14, 2019 /s/ Michael McMullen
Michael McMullen
Chief Financial Officer 

 

 

 

EX-101.INS 5 qsep-20190630.xml XBRL INSTANCE FILE 0001103795 2018-12-31 0001103795 2019-01-01 2019-06-30 0001103795 2018-01-01 2018-06-30 0001103795 2019-06-30 0001103795 2017-12-31 0001103795 2018-06-30 0001103795 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001103795 us-gaap:CommonStockMember 2018-12-31 0001103795 us-gaap:CommonStockMember 2019-06-30 0001103795 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001103795 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001103795 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001103795 us-gaap:RetainedEarningsMember 2018-12-31 0001103795 us-gaap:RetainedEarningsMember 2019-06-30 0001103795 us-gaap:StockOptionMember 2019-01-01 2019-06-30 0001103795 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001103795 us-gaap:ConvertibleDebtMember 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember 2018-01-01 2018-06-30 0001103795 us-gaap:WarrantMember 2018-01-01 2018-06-30 0001103795 us-gaap:ConvertibleDebtMember 2018-01-01 2018-06-30 0001103795 qsep:PatentCostsMember 2019-01-01 2019-06-30 0001103795 qsep:PatentCostsMember 2018-01-01 2018-06-30 0001103795 qsep:FormerExecutiveMember 2019-06-30 0001103795 qsep:FormerExecutiveMember 2018-12-31 0001103795 us-gaap:OfficeEquipmentMember 2019-06-30 0001103795 us-gaap:FurnitureAndFixturesMember 2019-06-30 0001103795 qsep:TestingEquipmentMember 2019-06-30 0001103795 us-gaap:LeaseholdImprovementsMember 2019-06-30 0001103795 us-gaap:OfficeEquipmentMember 2018-12-31 0001103795 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001103795 qsep:TestingEquipmentMember 2018-12-31 0001103795 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001103795 qsep:AOTPrototypeMember 2019-01-01 2019-06-30 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2019-01-01 2019-06-30 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2018-01-01 2018-06-30 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2019-06-30 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2018-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember qsep:AccountsPayableDeferredMember 2019-06-30 0001103795 qsep:TempleUniversityLicenseAgreementsMember qsep:AccountPayablePastDueMember 2019-06-30 0001103795 us-gaap:ConvertibleNotesPayableMember 2019-01-01 2019-06-30 0001103795 qsep:WarrantExercisesMember 2019-01-01 2019-06-30 0001103795 qsep:OptiontExercisesMember 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember 2018-12-31 0001103795 us-gaap:StockOptionMember 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice1Member 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice1Member 2019-06-30 0001103795 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001103795 us-gaap:WarrantMember 2018-12-31 0001103795 us-gaap:WarrantMember 2019-06-30 0001103795 us-gaap:WarrantMember qsep:Warrant1Member 2019-01-01 2019-06-30 0001103795 us-gaap:WarrantMember qsep:Warrant1Member 2019-06-30 0001103795 us-gaap:WarrantMember qsep:Warrant2Member 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:BoardOfDirectorsMember 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember 2018-01-01 2018-06-30 0001103795 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001103795 us-gaap:CommonStockMember 2017-12-31 0001103795 us-gaap:CommonStockMember 2018-06-30 0001103795 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001103795 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001103795 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001103795 us-gaap:RetainedEarningsMember 2017-12-31 0001103795 us-gaap:RetainedEarningsMember 2018-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice2Member 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice2Member 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice3Member 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice3Member 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice4Member 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember qsep:OptionPrice4Member 2019-06-30 0001103795 us-gaap:WarrantMember qsep:Warrant2Member 2019-01-01 2019-06-30 0001103795 us-gaap:WarrantMember qsep:Warrant3Member 2019-01-01 2019-06-30 0001103795 us-gaap:WarrantMember qsep:Warrant3Member 2019-06-30 0001103795 2019-08-13 0001103795 2019-04-01 2019-06-30 0001103795 2018-04-01 2018-06-30 0001103795 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001103795 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001103795 us-gaap:CommonStockMember 2019-03-31 0001103795 us-gaap:CommonStockMember 2018-03-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001103795 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001103795 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001103795 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001103795 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001103795 us-gaap:RetainedEarningsMember 2019-03-31 0001103795 us-gaap:RetainedEarningsMember 2018-03-31 0001103795 2019-03-31 0001103795 2018-03-31 0001103795 qsep:AOTPrototypeMember 2018-01-01 2018-06-30 0001103795 qsep:AOTPrototypeMember 2018-04-01 2018-06-30 0001103795 qsep:AOTPrototypeMember 2019-04-01 2019-06-30 0001103795 qsep:AOTPrototypeMember 2019-06-30 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2019-04-01 2019-06-30 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2018-04-01 2018-06-30 0001103795 qsep:StockIssuedServicesMember 2019-01-01 2019-06-30 0001103795 us-gaap:StockOptionMember 2019-04-01 2019-06-30 0001103795 us-gaap:StockOptionMember 2018-04-01 2018-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 0.001 0.001 500000000 500000000 73000 76000 256123515 298457191 256123515 298457191 0001103795 10-Q 2019-06-30 false --12-31 Yes Non-accelerated Filer Q2 2019 1100000 369000 38406486 3138992 538197 4624125 1686666 3345375 true false 55000 0 1073000 1137000 1137000 1073000 135000 1002000 583000 95000 489000 94000 94000 432000 48000 1000 1000 384000 47000 47000 1133000 956000 9000 12000 655000 462000 273000 647000 202000 202000 194000 245000 183000 535000 85000 102000 77948350 47595157 39450603 25713204 12784543 37301300 5006355 5287502 267000 327000 97000 97000 30000 5000 37000 25000 30000 5000 37000 25000 3000 17000 1000 9000 1886000 1073000 123000 151000 2009000 1224000 112000 1118000 2045000 205000 38406486 38406486 491000 538197 71000 35301300 39450603 17915553 20913552 471052 150446 4687500 4687500 0 0.22 0.20 0.10 0.27 0.85 1.18 0.08 0.08 0.13 P5Y2M12D P8Y P2Y9M18D P4Y9M18D P4Y1M6D 37237063 15702013 20913552 471052 150446 0.21 0.10 0.08 .06 0.30 0.27 0.85 1.18 0.80 21055355 25713204 23643204 2000000 70000 9099204 3138993 1302362 0.09 0.08 0.08 0.07 .19 P8M12D P7M6D P2Y3M19D P4Y9M18D .07 .06 0.30 0.80 25647204 23577204 2000000 70000 328000 2553000 164000 4231000 9000000 34000 239000 1187000 950000 24000 21000 2000 2000 1213000 973000 658000 505000 909000 855000 2695000 2497000 256123 298456 111429877 115085544 -113168000 -116908000 1213000 973000 2024000 407000 33000 26000 371000 248000 500000 450000 450000 299149251 QS Energy, Inc. Yes NV 0-29185 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>1.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Description of Business</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">QS Energy, Inc. (&#8220;QS Energy&#8221;, &#8220;Company&#8221;) was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc. The Company&#8217;s common stock is quoted under the symbol &#8220;QSEP&#8221; on the Over-the-Counter Bulletin Board. More information including the Company&#8217;s fact sheet, logos and media articles are available at our corporate website, www.qsenergy.com.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">QS Energy develops and commercializes energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions. The Company's intellectual properties include a portfolio of domestic and international patents and patents pending, a substantial portion of which have been developed in conjunction with and exclusively licensed from Temple University of Philadelphia, PA (&#8220;Temple&#8221;). QS Energy's primary technology is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product. Engineered specifically to reduce pipeline pressure loss, increase pipeline flow rate and capacity, and reduce shippers&#8217; reliance on diluents and drag reducing agents to meet pipeline maximum viscosity requirements, AOT is a 100% solid-state system that reduces crude oil viscosity by applying a high intensity electrical field to crude oil feedstock while in transit. The AOT product is seeking to transition from the research and development stage to initial production for continued testing in advance of our goal of seeking acceptance and adoption by the midstream pipeline marketplace.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the SEC. The condensed consolidated balance sheet as of December 31, 2018 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>2.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Summary of Significant Accounting Policies</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Consolidation Policy</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated financial statements of QS Energy Inc. include the accounts of QS Energy Inc. (the Parent) and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><br /></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Going Concern</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the six-months ended June 30, 2019, the Company incurred a net loss of $3,740,000, used cash in operations of $1,833,000 and had a stockholders&#8217; deficit of $1,524,000 as of that date. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company&#8217;s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2018 financial statements, has raised substantial doubt about the Company's ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June 30, 2019, the Company had cash on hand in the amount of $711,000. Management estimates that the current funds on hand will be sufficient to continue operations through November 2019, or, subject to actual costs incurred implementing design modifications to our AOT demonstration project described in Part I, Item 2, October 2019. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain payments to a former officer and consulting fees, during the remainder of 2019 and beyond.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Basic and Diluted Income (loss) per share</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our computation of earnings per share (&#8220;EPS&#8221;) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an antidilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the Company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. At June 30, 2019 and 2019, we excluded the outstanding securities summarized below, which entitle the holders thereof to acquire shares of common stock as their effect would have been anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Options</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">39,450,603</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">37,301,300</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Warrants</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">25,713,204</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5,006,355</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Common stock issuable upon conversion of notes payable</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,784,543</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,287,502</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,948,350</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">47,595,157</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Estimates</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Revenue Recognition Policy</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that supersedes nearly all existing revenue recognition guidance under current U.S. GAAP and replaces it with a principle-based approach or determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Research and Development Costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development costs are expensed as incurred and consist primarily of fees paid to consultants and outside service providers, and other expenses relating to the acquisition, design, development and testing of the Company&#8217;s products. Certain research and development activities are incurred under contract. In those instances, research and development costs are charged to operations ratably over the life of the underlying contracts, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. Payments made pursuant to research and development contracts are initially recorded as advances on research and development contract services in the Company&#8217;s consolidated balance sheet and then charged to research and development costs in the Company&#8217;s consolidated statement of operations as those contract services are performed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In January 2019, the Company paid $500,000 as a deposit under terms of a work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized <font style="background-color: white">$450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining</font> amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the six-month periods ended June 30, 2019 and 2018 research and development costs were $583,000 and $95,000, respectively. For the three-month periods ended June 30, 2019 and 2018 research and development costs were $432,000 and $48,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Patent Costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT and Joule Heat products, all patent costs are expensed as incurred. During the six-month periods ended June 30, 2019 and 2018, patent costs were $9,000 and $12,000, respectively, which is included as part of operating expenses in the accompanying consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Recent Accounting Pronouncements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statement presentation or disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Consolidation Policy</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated financial statements of QS Energy Inc. include the accounts of QS Energy Inc. (the Parent) and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Basic and Diluted Income (loss) per share</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our computation of earnings per share (&#8220;EPS&#8221;) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an antidilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the Company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. At June 30, 2019 and 2019, we excluded the outstanding securities summarized below, which entitle the holders thereof to acquire shares of common stock as their effect would have been anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Options</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">39,450,603</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">37,301,300</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Warrants</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">25,713,204</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5,006,355</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Common stock issuable upon conversion of notes payable</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,784,543</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,287,502</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,948,350</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">47,595,157</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Estimates</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Revenue Recognition Policy</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that supersedes nearly all existing revenue recognition guidance under current U.S. GAAP and replaces it with a principle-based approach or determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Research and Development Costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development costs are expensed as incurred and consist primarily of fees paid to consultants and outside service providers, and other expenses relating to the acquisition, design, development and testing of the Company&#8217;s products. Certain research and development activities are incurred under contract. In those instances, research and development costs are charged to operations ratably over the life of the underlying contracts, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. Payments made pursuant to research and development contracts are initially recorded as advances on research and development contract services in the Company&#8217;s consolidated balance sheet and then charged to research and development costs in the Company&#8217;s consolidated statement of operations as those contract services are performed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In January 2019, the Company paid $500,000 as a deposit under terms of a work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized <font style="background-color: white">$450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining</font> amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the six-month periods ended June 30, 2019 and 2018 research and development costs were $583,000 and $95,000, respectively. For the three-month periods ended June 30, 2019 and 2018 research and development costs were $432,000 and $48,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Patent Costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT and Joule Heat products, all patent costs are expensed as incurred. During the six-month periods ended June 30, 2019 and 2018, patent costs were $9,000 and $12,000, respectively, which is included as part of operating expenses in the accompanying consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Recent Accounting Pronouncements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statement presentation or disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>3.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accrued Expenses and Accounts Payable</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Accrued Expenses</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June 30, 2019 and December 31, 2018, the Company owed $267,000 and $327,000, respectively, pursuant to a separation agreement with a former executive officer effective April 1, 2017 as amended by letter agreements dated effective August 16, 2018 and March 31, 2019 which included as part of Accrued expenses and accounts payable on the accompanying balance sheet. The amount is to be repaid at an amount of $10,000 per month.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Accrued Expenses and Accounts Payable &#8211; Related Parties</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accrued expense &#8211; related parties consists of accrued current salaries of officers and fees due to members of the Board of Directors. As of June 30, 2019, and December 31, 2018, accrued expenses and accounts payable to related parties amounted to $0 and $55,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>4.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Property and Equipment</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June 30, 2019 and December 31, 2018, property and equipment consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,<br /> 2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Office equipment</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Testing Equipment</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">37,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">37,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Leasehold Improvements</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Subtotal</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">97,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">97,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(76,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(73,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depreciation expense for the six-month periods ended June 30, 2019 and 2018 was $3,000 and $17,000, respectively. Depreciation expense for the three-month periods ended June 30, 2019 and 2018 was $1,000 and $9,000, respectively.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,<br /> 2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Office equipment</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Testing Equipment</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">37,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">37,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Leasehold Improvements</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Subtotal</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">97,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">97,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(76,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(73,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, <br /> 2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Options</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">39,450,603</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">37,301,300</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Warrants</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">25,713,204</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5,006,355</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Common stock issuable upon conversion of notes payable</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,784,543</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,287,502</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,948,350</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">47,595,157</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>5.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Convertible Notes</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30,<br /> 2019</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2018</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Balance due on convertible notes</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,073,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,886,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">151,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">123,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Subtotal</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,224,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,009,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Convertible note discount</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(369,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,100,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Balance on convertible notes, net of note discounts</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">855,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">909,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issues convertible notes in exchange for cash. The notes typically do not bear any interest; however, there is an implied interest rate of 10% since the notes are typically issued at a 10% discount. The notes are unsecured, and usually mature twelve months from issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The notes are convertible at the option of the note holder into the Company&#8217;s common stock at a conversion price stipulated in the conversion agreement. In addition, the note holders receive warrants to purchase shares of common stock that are fully vested and will expire in one year from the date of issuance. As a result, the Company records a note discount to account for the relative fair value of the warrants, the notes&#8217; beneficial conversion feature or BCF, and original issue discount of 10% (OID). The note discounts are amortized over the term of the notes or amortized in full upon its conversion to common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2018, total outstanding notes payable amounted to $1,886,000 which are due through December 2019 and unamortized note discount of $1,100,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six-month period ended June 30, 2019, the Company issued similar convertible promissory notes in the aggregate of $1,230,000 for cash of $1,118,000 or a discount of $112,000. The notes do not bear any interest; however, the implied interest rate used was 10% since the notes were issued 10% less than its face value. The notes are unsecured, mature in twelve months from issuance and convertible at $0.05 to $0.15 per share. In addition, the Company also granted these note holders warrants to purchase 9.0 million shares of the Company&#8217; common stock. The warrants are fully vested, exercisable at $0.05 to $0.15 per share and will expire in one year. As a result, the Company recorded a note discount of $1,118,000 to account for the relative fair value of the warrants, the notes&#8217; beneficial conversion feature (BCF), and original issue discount (OID). The note discounts are being amortized over the term of the note or amortized in full upon the conversion to common stock. During the six-month period ended June 30, 2019 notes payable of $2,045,000 were converted into 38,406,486 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June 30, 2019, total outstanding notes payable amounted to $1,073,000, accrued interest of $151,000 and unamortized note discount of $369,000 for a net balance of $855,000. A total of nine notes in the aggregate of $491,000 have reached maturity and are past due.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30,<br /> 2019</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2018</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Balance due on convertible notes</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,073,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,886,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">151,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">123,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Subtotal</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,224,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,009,000</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Convertible note discount</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(369,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,100,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Balance on convertible notes, net of note discounts</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">855,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">909,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>6.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Research and Development</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company constructs, develops and tests the AOT technologies with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as license fees, prototype equipment fabrication and installation, purchase of test equipment, pipeline pumping equipment, crude oil tank batteries, viscometers, SCADA systems, computer equipment, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company&#8217;s AOT prototypes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Costs incurred for research and development are expensed as incurred. Purchased materials that do not have an alternative future use are also expensed. Furthermore, costs incurred in the construction of prototypes with no certainty of any alternative future use and established commercial uses are also expensed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the six-month periods ended June 30, 2019 and 2018, our research and development expenses were $583,000 and $95,000 respectively. For the three-month periods ended June 30, 2019 and 2018, our research and development expenses were $432,000 and $48,000 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>AOT Product Development and Testing</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company constructs, develops and tests the AOT technologies with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as prototype equipment fabrication and installation, testing fees, purchase of test equipment, pipeline pumping equipment, crude oil tank batteries, viscometers, SCADA systems, computer equipment, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company&#8217;s AOT prototypes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six-month periods ended June 30, 2019 and 2018, the Company incurred total expenses of $489,000 and $1,000, respectively, in the manufacture, delivery and testing of the AOT prototype equipment. During the three-month periods ended June 30, 2019 and 2018, the Company incurred total expenses of $384,000 and $1,000, respectively, in the manufacture, delivery and testing of the AOT prototype equipment. Included in this amount, were costs related to a $500,000 work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized $450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019. There were no such expenses for the comparable period in 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Temple University Licensing Agreement</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2011, the Company and Temple University (&#8220;Temple&#8221;) entered into two (2) Exclusive License Agreements (collectively, the &#8220;License Agreements&#8221;) relating to Temple&#8217;s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the &#8220;First Temple License&#8221;), and to technology to reduce crude oil viscosity (the &#8220;Second Temple License&#8221;). The License Agreements are exclusive, and the territory licensed to the Company is worldwide and replace previously issued License Agreements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the two licensing agreements, the Company paid Temple a non-refundable license maintenance fee of $300,000 and agreed to pay (i) annual maintenance fees of $187,500; (ii) royalty fee ranging from 4% up to 7% from revenues generated from the licensing agreements; and (iii) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. The term of the licenses commenced in August 2011 and will expire upon expiration of the patents. The agreements can also be terminated by either party upon notification under terms of the licensing agreements or if the Company ceases the development of the patent or fails to commercialize the patent rights.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Total expenses recognized during each six-month periods ended June 30, 2019 and 2018 pursuant to these two License Agreements amounted to $94,000 and $94,000, respectively. Total expenses recognized during each three-month periods ended June 30, 2019 and 2018 pursuant to these two License Agreements amounted to $47,000 and $47,000, respectively. Total expenses have been reflected in Research and Development expenses on the accompanying consolidated statements of operations. In the six-month periods ended June 30, 2019 and 2018, the Company also recognized penalty interest on past-due balances of $33,000 and $26,000, respectively, which is included as part of interest and financing expense in the accompanying statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June 30, 2019 and December 31, 2018, total unpaid fees due to Temple pursuant to these agreements are $1,137,000 and $1,073,000, respectively, which are included as part of Accounts Payable &#8211; license agreements in the accompanying consolidated balance sheets. With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $1,002,000 are deemed past due. The Company is currently in negotiations with Temple to settle or cure the past due balance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No revenues were earned from the two License Agreements during the six-month periods ended June 30, 2019 and June 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>7.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common Stock</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six months ended June 30, 2019, the Company issued 42,333,676 shares of its common stock as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font: 10pt Symbol">&#183;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company issued 38,406,486 shares of its common stock upon the conversion of $2,045,000 in convertible notes pursuant to the convertible notes conversion prices of $0.05 to $0.15 per share.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font: 10pt Symbol">&#183;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company issued 3,138,993 shares of its common stock upon the exercise of warrants for proceeds of $202,000 at exercise prices of $0.05 to $0.18 per share.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font: 10pt Symbol">&#183;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company issued 538,197 shares of its common stock upon the exercise of options for proceeds of $71,000 at exercise prices of $0.08 to $0.18 per share.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font: 10pt Symbol">&#183;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company issued 250,000 shares of its common stock in exchange for $68,000 for services valued at $0.27 per share.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>8.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Stock Options and Warrants</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. Options vest and expire according to terms established at the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><u>Options</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Options vest according to the terms of the specific grant and expire from 2 to 10 years from date of grant. The weighted-average, remaining contractual life of employee and non-employee options outstanding at June 30, 2019 was 5.2 years. Stock option activity for the period January 1, 2019 up to June 30, 2019, was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted <br /> Avg. Exercise<br /> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 65%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">January 1, 2019</font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">35,301,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.22</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4,687,500</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(538,197</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.13</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2019</font></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,450,603</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.20</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest as of June 30, 2019 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: White"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding Options</b></font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercisable Options</b></font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Option </b><br /> <b>Exercise Price </b><br /> <b>Per Share</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Life </b><br /> <b>(Years)</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted </b><br /> <b>Average Exercise </b><br /> <b>Price</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted </b><br /> <b>Average Exercise </b><br /> <b>Price</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 14%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.05 - $0.24 </font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">17,915,553</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: center">8.0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">15,702,013</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.10</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.25 - $0.49 </font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">20,913,552</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: center">2.8</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">20,913,552</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.50 - $0.99 </font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">471,052</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: center">4.8</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.85</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">471,052</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.85</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$1.00 - $2.00 </font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">150,446</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">4.1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">1.18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">150,446</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">1.18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,450,603</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">5.2</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.20</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,237,063</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six-month period ending June 30, 2019, and pursuant to the Company&#8217;s Board Compensation policy approved by the Board June 19, 2015, the Company granted options to purchase 4,687,500 shares of common stock to members of the Company&#8217;s Board of Directors. The options are exercisable at $0.08 share, vest monthly over a twelve-month period, and expire ten years from the date granted. Total fair value of these options at grant date was $328,000 using the Black-Scholes Option Pricing model with the following assumptions: life of 5 years; risk free interest rate of 2.5%; volatility of 122% and dividend yield of 0%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six-month periods ended June 30, 2019 and 2018, the Company recognized compensation costs based on the fair value of options that vested of $183,000 and $535,000 respectively. During the three-month periods ended June 30, 2019 and 2018, the Company recognized compensation costs based on the fair value of options that vested of $85,000 and $102,000 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June 30, 2019, the Company&#8217;s closing stock price was $0.24 per share. The aggregate intrinsic value of the options outstanding at June 30, 2019 was $2,553,000. Future unamortized compensation expense on the unvested outstanding options at June 30, 2019 is approximately $164,000 to be recognized through December 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Warrants</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes certain information about the Company&#8217;s stock purchase warrants activity for the period starting January 1, 2019 up to June 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Avg.<br /> Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 67%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">January 1, 2019</font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">21,055,355</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.09</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">9,099,204</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(3,138,993</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.07</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,302,362</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.19</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2019</font></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,713,204</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.08</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The weighted average exercise prices, remaining contractual lives for warrants granted, exercisable, and expected to vest as of June 30, 2019 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: White"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding Warrants</b></font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercisable Warrants</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrant Exercise Price Per Share</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Life <br /> (Years)</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted <br /> Average Exercise Price</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted <br /> Average Exercise Price</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 14%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.05 - $0.24</font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">23,643,204</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: center">0.6</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">23,577,204</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.06</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.25 - $0.49</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: center">2.3</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.30</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.30</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.50 - $1.00</font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">4.8</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">0.80</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">0.80</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; border-bottom: Black 2.5pt double">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double">25,713,204</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt">0.7</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt">$</td><td style="text-align: right; padding-bottom: 2.5pt">0.08</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; border-bottom: Black 2.5pt double">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double">25,647,204</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt">$</td><td style="text-align: right; padding-bottom: 2.5pt">0.08</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the six-month period ending June 30, 2019, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 8,999,205 shares of common stock with an exercise price of $.05 to $0.18 per share, vesting immediately upon grant and expiring one year from the date of grant (see Note 5, above).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the six-month period ending June 30, 2019, the Company issued warrants to purchase 99,999 shares of common stock with an exercise price of $0.24 per share, vesting over three months and expiring two years from the date of grant as compensation under an independent consulting agreement. Total fair value of the warrants at grant date was $17,000 using the Black-Scholes model with the following assumptions: life of 2.3 years; risk free interest rate of 1.75%; volatility of 153% and dividend yield of 0%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the six-month period ended June 30, 2019, warrants to acquire 3,138,993 shares of common stock were exercised resulting in net proceeds to the Company of $202,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June 30, 2019, the aggregate intrinsic value of the warrants outstanding was $4,231,000.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted <br /> Avg. Exercise<br /> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 65%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">January 1, 2019</font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">35,301,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.22</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4,687,500</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(538,197</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.13</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2019</font></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,450,603</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.20</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: White"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding Options</b></font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercisable Options</b></font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Option </b><br /> <b>Exercise Price </b><br /> <b>Per Share</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Life </b><br /> <b>(Years)</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted </b><br /> <b>Average Exercise </b><br /> <b>Price</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted </b><br /> <b>Average Exercise </b><br /> <b>Price</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 14%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.05 - $0.24 </font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">17,915,553</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: center">8.0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">15,702,013</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.10</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.25 - $0.49 </font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">20,913,552</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: center">2.8</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">20,913,552</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.50 - $0.99 </font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">471,052</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: center">4.8</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.85</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">471,052</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.85</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$1.00 - $2.00 </font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">150,446</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">4.1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">1.18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">150,446</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">1.18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,450,603</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">5.2</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.20</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,237,063</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Avg.<br /> Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 67%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">January 1, 2019</font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">21,055,355</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.09</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">9,099,204</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(3,138,993</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.07</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,302,362</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.19</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2019</font></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,713,204</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.08</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: White"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding Warrants</b></font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercisable Warrants</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrant Exercise Price Per Share</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Life <br /> (Years)</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted <br /> Average Exercise Price</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted <br /> Average Exercise Price</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 14%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.05 - $0.24</font></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">23,643,204</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: center">0.6</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">23,577,204</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.06</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.25 - $0.49</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: center">2.3</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.30</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.30</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.50 - $1.00</font></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">4.8</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">0.80</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">0.80</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; border-bottom: Black 2.5pt double">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double">25,713,204</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="text-align: center; padding-bottom: 2.5pt">0.7</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt">$</td><td style="text-align: right; padding-bottom: 2.5pt">0.08</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt; border-bottom: Black 2.5pt double">&#160;</td><td style="text-align: right; border-bottom: Black 2.5pt double">25,647,204</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 2.5pt">$</td><td style="text-align: right; padding-bottom: 2.5pt">0.08</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>9.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Commitments and Contingencies</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no current or pending litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.</p> 1153000 711000 204000 493000 -1482000 -1524000 -1874000 -1772000 256123 298456 111429877 115085544 -113168000 -116908000 234077 251448 108000923 109543552 -110109000 -111567000 294805 236752 114166195 108568248 -115450000 -110809000 -989000 -2004000 0 0 0 0 -1716000 -1051000 -1087000 -510000 -3740000 -1458000 -3740000 -1458000 -1458000 -758000 -1458000 -758000 -0.01 -0.01 -0.00 0.00 279658273 238825606 293284367 242994163 256123515 298457191 234076907 251448515 294805488 236751367 3677190 12697483 1715037 11351773 273000 647000 3677 269323 12697 634303 101000 576000 1715 11351 99285 564649 2045000 337000 38406 2006594 4624 332376 209000 238000 1686 3345 207314 234655 1118000 319000 1118000 319000 450000 74000 450000 74000 194000 245000 194000 245000 95000 102000 95000 102000 250000 50000 250000 250000 68000 12000 250 67750 50 11950 68000 250 67750 68000 68000 12000 1991000 381000 3000 17000 205000 -6000 -153000 -13000 64000 122000 -55000 12000 0 0 -1833000 -676000 1118000 318000 1391000 965000 -442000 289000 0 0 1600 1600 1230000 50000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif"><b>10.</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Subsequent Events</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Conversion of Convertible Notes</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From July 1, 2019 up to August 13, 2019, Company issued 329,560 shares of common stock upon conversion of previously issued convertible notes in aggregate value of $50,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Exercise of Warrants</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From July 1, 2019 up to August 13, 2019, Company issued 362,500 shares of common stock upon the exercise of previously issued warrants for aggregate cash proceeds of $19,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>Going Concern</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the six-months ended June 30, 2019, the Company incurred a net loss of $3,740,000, used cash in operations of $1,833,000 and had a stockholders&#8217; deficit of $1,524,000 as of that date. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company&#8217;s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2018 financial statements, has raised substantial doubt about the Company's ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At June 30, 2019, the Company had cash on hand in the amount of $711,000. Management estimates that the current funds on hand will be sufficient to continue operations through November 2019, or, subject to actual costs incurred implementing design modifications to our AOT demonstration project described in Part I, Item 2, October 2019. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain payments to a former officer and consulting fees, during the remainder of 2019 and beyond.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.</p> EX-101.SCH 6 qsep-20190630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 1. Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 2. Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 3. Accrued Expenses and Accounts Payable - Related Parties link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 4. Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 5. Convertible Notes link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 6. Research and Development link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 7. Common Stock link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 8. Stock Options and Warrants link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 9. Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 10. Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 2. Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 4. Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 5. Convertible Notes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 8. Stock Options and Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 2. Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 3. Accrued Expenses and Accounts Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 4. Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 4. Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 5. Convertible Notes (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 5. Convertible Notes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 6. Research and Development (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 7. Common Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 8. Stock Options and Warrants (Details-Options Outstanding) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 8. Stock Options and Warrants (Details-Options by Exercise Price Per Share) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 8. Stock Options and Warrants (Details-Warrants Outstanding) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 8. Stock Options and Warrants (Details-Warrant Exercise Price per Share) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - 8. Stock options and Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 qsep-20190630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 qsep-20190630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 qsep-20190630_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock Additional Paid-In Capital Accumulated Deficit Antidilutive Securities [Axis] Options [Member] Warrants [Member] Convertible Notes [Member] Income Statement Location [Axis] Patent Costs [Member] Counterparty Name [Axis] Former Executive [Member] Property, Plant and Equipment, Type [Axis] Office equipment [Member] Furniture and fixtures [Member] Testing equipment [Member] Leasehold Improvements [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] AOT Prototypes [Member] Temple University License Agreements [Member] Balance Sheet Location [Axis] Accounts payable deferred [Member] Accounts payable past due [Member] Stock Conversion Description [Axis] Convertible Notes Payable [Member] Warrant Exercises [Member] Options Exercises [Member] Award Type [Axis] Exercise Price Range [Axis] $0.05 - $0.24 [Member] $0.05-$0.24 Price Per Share [Member] $0.25-$0.49 Price Per Share [Member] Board of Directors [Member] $0.25 - $0.49 [Member] $0.50 - $0.99 [Member] $1.00 - $2.00 [Member] $0.50-$1.00 Price Per Share [Member] Nonmonetary Transaction Type [Axis] Stock issued for services [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Entity Small Business Entity Emerging Growth Entity Interactive Data Current Entity Incorporation State Country Code Entity File Number Statement of Financial Position [Abstract] ASSETS Current assets: Cash Prepaid expenses and other current assets Total current assets Property and equipment, net of accumulated depreciation of $76,000 and $73,000 at June 30, 2019 and December 31, 2018, respectively Other assets Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable-license agreements Accounts payable and accrued expenses Accrued expenses and accounts payable-related parties Convertible debentures, net of discounts of $369,000 and $1,100,000 at June 30, 2019 and December 31, 2018, respectively Total current liabilities Commitments and contingencies Stockholders' deficit Common stock, $.001 par value: 500,000,000 shares authorized, 298,457,191 and 256,123,515 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively Additional paid-in capital Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Accumulated depreciation Discounts on convertible debentures Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Costs and Expenses Operating expenses Research and development expenses Loss before other expenses Other expense Interest and financing expense Net loss Net loss per common share, basic and diluted Weighted average common shares outstanding, basic and diluted Statement [Table] Statement [Line Items] Beginning balance, shares Beginning balance, value Common stock issued on exercise of warrants and options, shares Common stock issued on exercise of warrants and options, value Common stock issued on conversion of notes payable, shares Common stock issued on conversion of notes payable, value Fair value of warrants and beneficial conversion feature of issued convertible notes Fair value of options and warrants issued as compensation Common stock issued for services, shares Common stock issued for services, value Net loss Ending balance, shares Ending balance, value Statement of Cash Flows [Abstract] Cash flows from operating activities Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation expense Issuance of common stock for services Amortization of debt discount and of interest expense Depreciation and amortization Changes in operating assets and liabilities: Prepaid expenses and other assets Accounts payable and accrued expenses Accounts payable - license agreements Accounts payable and accrued expenses - related parties Deposits and other current liabilities Net cash used in operating activities Cash flows from investing activities Net cash used in investing activities Cash flows from financing activities Net proceeds from issuance of convertible notes and warrants Net proceeds from exercise of warrants Net cash provided by financing activities Net increase (decrease) in cash Cash, beginning of period Cash, end of period Supplemental disclosures of cash flow information Cash paid during the year for: Interest Cash paid during the year for: Income taxes Non-cash investing and financing activities Conversion of convertible debentures to common stock Fair value of warrants and beneficial conversion feature associated with issued convertible notes Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business Accounting Policies [Abstract] Summary of Significant Accounting Policies Payables and Accruals [Abstract] Accrued Expenses and Accounts Payable - Related Parties Property, Plant and Equipment [Abstract] Property and Equipment Debt Disclosure [Abstract] Convertible Notes Research and Development [Abstract] Research and Development Stockholders' Equity Note [Abstract] Common Stock Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Stock Options and Warrants Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Consolidation Policy Going Concern Basic and Diluted Income (Loss) per Share Estimates Revenue Recognition Policy Research and Development Costs Patent Costs Recent Accounting Pronouncements Antidilutive shares Property and equipment Convertible Notes and Warrants Stock options outstanding Options outstanding by Per Share Price Warrants outstanding Warrants outstanding by Per Share Price Antidilutive shares excluded from EPS Cash flow from operations Stockholders' deficit Cash on Hand Payment for deposit for work to be performed Amortization of prepaid deposit Research and development costs Severance payable Accrued salaries of officers and fees due to members of the Board of Directors Property and equipment, gross Less: accumulated depreciation Property and equipment, net Depreciation expense Balance due on convertible notes Accrued Interest Convertible notes payable, gross Convertible note discount Balance on convertible notes, net of note discount Notes payable balance Unamortized discount Convertible notes, face amount Proceeds from convertible notes Discount on notes issued Warrants issued with notes, shares Discount on fair value of warrants, BCF and OID Debt converted, amount converted Debt converted, shares issued Accrued penalty interest Convertible notes outstanding, net Debt in default Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Research and Development Arrangement, Contract to Perform for Others [Line Items] Accounts payable - licensing agreement License revenue generated Interest and financing expense Prepaid expenses Stock issued upon the exercise of options or warrants, shares issued Proceeds from warrant exercises Proceeds from options exercised Stock issued for services, shares issued Stock issued for services, value Beginning Balance Granted Exercised Forfeited Ending Balance Weighted Average Exercise Price, Outstanding Beginning Balance Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Forfeited Weighted Average Exercise Price, Outstanding Ending Balance Outstanding Options Options outstanding Life (Years), options outstanding Weighted Average Exercise Price, options outstanding Exercisable Options Options exercisable Weighted Average Exercise Price, options exercisable Warrants outstanding, beginning balance Warrants granted Warrants exercised Warrants cancelled Warrants outstanding, ending balance Weighted Average Exercise Price, Outstanding Beginning Balance Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Cancelled Weighted Average Exercise Price, Outstanding Ending Balance Outstanding Warrants Warrants outstanding Life (Years), warrants outstanding Weighted Average Exercise Price, warrants outstanding Exercisable Warrants Warrants exercisable Weighted Average Exercise Price, warrants exercisable Options granted Option exercise price Fair value of options at grant date Share based compensation expense Aggregate intrinsic value of options outstanding Aggregate intrinsic value of warrants outstanding Unamortized compensation expense Weighted average life of options Warrants exercised AOT Prototype Member Accounts payable - past due [Member] Accounts Payable - deferred [Member] Common stock issued on exercise of warrants and options, shares Common stock issued on exercise of warrants and options, value Discount on notes issued Options Exercisable [Abstract] Warrants exercisable [Abstract] Fair value of options at grant date Outstanding options [Abstract] Warrants outstanding [Abstract] Warrants outstanding by Per Share Price [Table Text Block] Severance payable Temple university license agreements. Testing Equipment Member Warrants issued with notes, shares Assets, Current Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease) Stockholders' Equity Note Disclosure [Text Block] Convertible Notes Payable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Class of Warrant or Right, Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations Class of Warrant or Right, Exercise Price of Warrants or Rights Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value EX-101.PRE 10 qsep-20190630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2019
Aug. 13, 2019
Document And Entity Information    
Entity Registrant Name QS Energy, Inc.  
Entity Central Index Key 0001103795  
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   299,149,251
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2019  
Entity Small Business true  
Entity Emerging Growth false  
Entity Interactive Data Current Yes  
Entity Incorporation State Country Code NV  
Entity File Number 0-29185  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash $ 711,000 $ 1,153,000
Prepaid expenses and other current assets 239,000 34,000
Total current assets 950,000 1,187,000
Property and equipment, net of accumulated depreciation of $76,000 and $73,000 at June 30, 2019 and December 31, 2018, respectively 21,000 24,000
Other assets 2,000 2,000
Total assets 973,000 1,213,000
Current liabilities:    
Accounts payable-license agreements 1,137,000 1,073,000
Accounts payable and accrued expenses 505,000 658,000
Accrued expenses and accounts payable-related parties 0 55,000
Convertible debentures, net of discounts of $369,000 and $1,100,000 at June 30, 2019 and December 31, 2018, respectively 855,000 909,000
Total current liabilities 2,497,000 2,695,000
Commitments and contingencies
Stockholders' deficit    
Common stock, $.001 par value: 500,000,000 shares authorized, 298,457,191 and 256,123,515 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively 298,456 256,123
Additional paid-in capital 115,085,544 111,429,877
Accumulated deficit (116,908,000) (113,168,000)
Total stockholders' deficit (1,524,000) (1,482,000)
Total liabilities and stockholders' deficit $ 973,000 $ 1,213,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Accumulated depreciation $ 76,000 $ 73,000
Discounts on convertible debentures $ 369,000 $ 1,100,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 298,457,191 256,123,515
Common stock, shares outstanding 298,457,191 256,123,515
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 655,000 462,000 1,133,000 956,000
Research and development expenses 432,000 48,000 583,000 95,000
Loss before other expenses (1,087,000) (510,000) (1,716,000) (1,051,000)
Other expense        
Interest and financing expense (371,000) (248,000) (2,024,000) (407,000)
Net loss $ (1,458,000) $ (758,000) $ (3,740,000) $ (1,458,000)
Net loss per common share, basic and diluted $ (0.00) $ 0.00 $ (0.01) $ (0.01)
Weighted average common shares outstanding, basic and diluted 293,284,367 242,994,163 279,658,273 238,825,606
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2017 234,076,907      
Beginning balance, value at Dec. 31, 2017 $ 234,077 $ 108,000,923 $ (110,109,000) $ (1,874,000)
Common stock issued on exercise of warrants and options, shares 12,697,483      
Common stock issued on exercise of warrants and options, value $ 12,697 634,303   647,000
Common stock issued on conversion of notes payable, shares 4,624,125      
Common stock issued on conversion of notes payable, value $ 4,624 332,376   337,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   319,000   319,000
Fair value of options and warrants issued as compensation   245,000   245,000
Common stock issued for services, shares 50,000      
Common stock issued for services, value $ 50 11,950   12,000
Net loss     (1,458,000) (1,458,000)
Ending balance, shares at Jun. 30, 2018 251,448,515      
Ending balance, value at Jun. 30, 2018 $ 251,448 109,543,552 (111,567,000) (1,772,000)
Beginning balance, shares at Mar. 31, 2018 236,751,367      
Beginning balance, value at Mar. 31, 2018 $ 236,752 108,568,248 (110,809,000) (2,004,000)
Common stock issued on exercise of warrants and options, shares 11,351,773      
Common stock issued on exercise of warrants and options, value $ 11,351 564,649   576,000
Common stock issued on conversion of notes payable, shares 3,345,375      
Common stock issued on conversion of notes payable, value $ 3,345 234,655   238,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   74,000   74,000
Fair value of options and warrants issued as compensation   102,000   102,000
Net loss     (758,000) (758,000)
Ending balance, shares at Jun. 30, 2018 251,448,515      
Ending balance, value at Jun. 30, 2018 $ 251,448 109,543,552 (111,567,000) (1,772,000)
Beginning balance, shares at Dec. 31, 2018 256,123,515      
Beginning balance, value at Dec. 31, 2018 $ 256,123 111,429,877 (113,168,000) (1,482,000)
Common stock issued on exercise of warrants and options, shares 3,677,190      
Common stock issued on exercise of warrants and options, value $ 3,677 269,323   273,000
Common stock issued on conversion of notes payable, shares 38,406,486      
Common stock issued on conversion of notes payable, value $ 38,406 2,006,594   2,045,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   1,118,000   1,118,000
Fair value of options and warrants issued as compensation   194,000   194,000
Common stock issued for services, shares 250,000      
Common stock issued for services, value $ 250 67,750   68,000
Net loss     (3,740,000) (3,740,000)
Ending balance, shares at Jun. 30, 2019 298,457,191      
Ending balance, value at Jun. 30, 2019 $ 298,456 115,085,544 (116,908,000) (1,524,000)
Beginning balance, shares at Mar. 31, 2019 294,805,488      
Beginning balance, value at Mar. 31, 2019 $ 294,805 114,166,195 (115,450,000) (989,000)
Common stock issued on exercise of warrants and options, shares 1,715,037      
Common stock issued on exercise of warrants and options, value $ 1,715 99,285   101,000
Common stock issued on conversion of notes payable, shares 1,686,666      
Common stock issued on conversion of notes payable, value $ 1,686 207,314   209,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   450,000   450,000
Fair value of options and warrants issued as compensation   95,000   95,000
Common stock issued for services, shares 250,000      
Common stock issued for services, value $ 250 67,750   68,000
Net loss     (1,458,000) (1,458,000)
Ending balance, shares at Jun. 30, 2019 298,457,191      
Ending balance, value at Jun. 30, 2019 $ 298,456 $ 115,085,544 $ (116,908,000) $ (1,524,000)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities    
Net Loss $ (3,740,000) $ (1,458,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation expense 194,000 245,000
Issuance of common stock for services 68,000 12,000
Amortization of debt discount and of interest expense 1,991,000 381,000
Depreciation and amortization 3,000 17,000
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (205,000) 6,000
Accounts payable and accrued expenses (153,000) (13,000)
Accounts payable - license agreements 64,000 122,000
Accounts payable and accrued expenses - related parties (55,000) 12,000
Deposits and other current liabilities 0 0
Net cash used in operating activities (1,833,000) (676,000)
Cash flows from financing activities    
Net proceeds from issuance of convertible notes and warrants 1,118,000 318,000
Net proceeds from exercise of warrants 273,000 647,000
Net cash provided by financing activities 1,391,000 965,000
Net increase (decrease) in cash (442,000) 289,000
Cash, beginning of period 1,153,000 204,000
Cash, end of period 711,000 493,000
Supplemental disclosures of cash flow information    
Cash paid during the year for: Interest 0 0
Cash paid during the year for: Income taxes 1,600 1,600
Non-cash investing and financing activities    
Conversion of convertible debentures to common stock 2,045,000 337,000
Fair value of warrants and beneficial conversion feature associated with issued convertible notes $ 1,118,000 $ 319,000
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.2
1. Description of Business
6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business

  1. Description of Business

 

QS Energy, Inc. (“QS Energy”, “Company”) was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc. The Company’s common stock is quoted under the symbol “QSEP” on the Over-the-Counter Bulletin Board. More information including the Company’s fact sheet, logos and media articles are available at our corporate website, www.qsenergy.com.

 

QS Energy develops and commercializes energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions. The Company's intellectual properties include a portfolio of domestic and international patents and patents pending, a substantial portion of which have been developed in conjunction with and exclusively licensed from Temple University of Philadelphia, PA (“Temple”). QS Energy's primary technology is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product. Engineered specifically to reduce pipeline pressure loss, increase pipeline flow rate and capacity, and reduce shippers’ reliance on diluents and drag reducing agents to meet pipeline maximum viscosity requirements, AOT is a 100% solid-state system that reduces crude oil viscosity by applying a high intensity electrical field to crude oil feedstock while in transit. The AOT product is seeking to transition from the research and development stage to initial production for continued testing in advance of our goal of seeking acceptance and adoption by the midstream pipeline marketplace.

 

Basis of Presentation

 

The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the SEC. The condensed consolidated balance sheet as of December 31, 2018 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.19.2
2. Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

  2. Summary of Significant Accounting Policies

 

Consolidation Policy

 

The accompanying consolidated financial statements of QS Energy Inc. include the accounts of QS Energy Inc. (the Parent) and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.


Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the six-months ended June 30, 2019, the Company incurred a net loss of $3,740,000, used cash in operations of $1,833,000 and had a stockholders’ deficit of $1,524,000 as of that date. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2018 financial statements, has raised substantial doubt about the Company's ability to continue as a going concern.

 

At June 30, 2019, the Company had cash on hand in the amount of $711,000. Management estimates that the current funds on hand will be sufficient to continue operations through November 2019, or, subject to actual costs incurred implementing design modifications to our AOT demonstration project described in Part I, Item 2, October 2019. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain payments to a former officer and consulting fees, during the remainder of 2019 and beyond.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.

  

Basic and Diluted Income (loss) per share

 

Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an antidilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the Company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. At June 30, 2019 and 2019, we excluded the outstanding securities summarized below, which entitle the holders thereof to acquire shares of common stock as their effect would have been anti-dilutive.

 

   June 30,
2019
   June 30,
2018
 
Options   39,450,603    37,301,300 
Warrants   25,713,204    5,006,355 
Common stock issuable upon conversion of notes payable   12,784,543    5,287,502 
Total   77,948,350    47,595,157 

 

Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.

 

Revenue Recognition Policy

 

Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that supersedes nearly all existing revenue recognition guidance under current U.S. GAAP and replaces it with a principle-based approach or determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.

 

Research and Development Costs

 

Research and development costs are expensed as incurred and consist primarily of fees paid to consultants and outside service providers, and other expenses relating to the acquisition, design, development and testing of the Company’s products. Certain research and development activities are incurred under contract. In those instances, research and development costs are charged to operations ratably over the life of the underlying contracts, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. Payments made pursuant to research and development contracts are initially recorded as advances on research and development contract services in the Company’s consolidated balance sheet and then charged to research and development costs in the Company’s consolidated statement of operations as those contract services are performed.

 

In January 2019, the Company paid $500,000 as a deposit under terms of a work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized $450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019.

 

For the six-month periods ended June 30, 2019 and 2018 research and development costs were $583,000 and $95,000, respectively. For the three-month periods ended June 30, 2019 and 2018 research and development costs were $432,000 and $48,000, respectively.

 

Patent Costs

 

Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT and Joule Heat products, all patent costs are expensed as incurred. During the six-month periods ended June 30, 2019 and 2018, patent costs were $9,000 and $12,000, respectively, which is included as part of operating expenses in the accompanying consolidated statements of operations.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statement presentation or disclosures.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.19.2
3. Accrued Expenses and Accounts Payable - Related Parties
6 Months Ended
Jun. 30, 2019
Payables and Accruals [Abstract]  
Accrued Expenses and Accounts Payable - Related Parties

  3. Accrued Expenses and Accounts Payable

 

Accrued Expenses

 

As of June 30, 2019 and December 31, 2018, the Company owed $267,000 and $327,000, respectively, pursuant to a separation agreement with a former executive officer effective April 1, 2017 as amended by letter agreements dated effective August 16, 2018 and March 31, 2019 which included as part of Accrued expenses and accounts payable on the accompanying balance sheet. The amount is to be repaid at an amount of $10,000 per month.

 

Accrued Expenses and Accounts Payable – Related Parties

 

Accrued expense – related parties consists of accrued current salaries of officers and fees due to members of the Board of Directors. As of June 30, 2019, and December 31, 2018, accrued expenses and accounts payable to related parties amounted to $0 and $55,000, respectively.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.19.2
4. Property and Equipment
6 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
Property and Equipment

  4. Property and Equipment

 

At June 30, 2019 and December 31, 2018, property and equipment consists of the following:

 

   June 30,
2019
   December 31,
2018
 
Office equipment  $30,000   $30,000 
Furniture and fixtures   5,000    5,000 
Testing Equipment   37,000    37,000 
Leasehold Improvements   25,000    25,000 
Subtotal   97,000    97,000 
Less accumulated depreciation   (76,000)   (73,000)
Total  $21,000   $24,000 

 

Depreciation expense for the six-month periods ended June 30, 2019 and 2018 was $3,000 and $17,000, respectively. Depreciation expense for the three-month periods ended June 30, 2019 and 2018 was $1,000 and $9,000, respectively.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.2
5. Convertible Notes
6 Months Ended
Jun. 30, 2019
Debt Disclosure [Abstract]  
Convertible Notes

  5. Convertible Notes

 

  

June 30,
2019

(unaudited)

  

December 31,

2018

 
Balance due on convertible notes  $1,073,000   $1,886,000 
Accrued interest   151,000    123,000 
Subtotal   1,224,000    2,009,000 
Convertible note discount   (369,000)   (1,100,000)
Balance on convertible notes, net of note discounts  $855,000   $909,000 

 

The Company issues convertible notes in exchange for cash. The notes typically do not bear any interest; however, there is an implied interest rate of 10% since the notes are typically issued at a 10% discount. The notes are unsecured, and usually mature twelve months from issuance.

 

The notes are convertible at the option of the note holder into the Company’s common stock at a conversion price stipulated in the conversion agreement. In addition, the note holders receive warrants to purchase shares of common stock that are fully vested and will expire in one year from the date of issuance. As a result, the Company records a note discount to account for the relative fair value of the warrants, the notes’ beneficial conversion feature or BCF, and original issue discount of 10% (OID). The note discounts are amortized over the term of the notes or amortized in full upon its conversion to common stock.

 

As of December 31, 2018, total outstanding notes payable amounted to $1,886,000 which are due through December 2019 and unamortized note discount of $1,100,000.

 

During the six-month period ended June 30, 2019, the Company issued similar convertible promissory notes in the aggregate of $1,230,000 for cash of $1,118,000 or a discount of $112,000. The notes do not bear any interest; however, the implied interest rate used was 10% since the notes were issued 10% less than its face value. The notes are unsecured, mature in twelve months from issuance and convertible at $0.05 to $0.15 per share. In addition, the Company also granted these note holders warrants to purchase 9.0 million shares of the Company’ common stock. The warrants are fully vested, exercisable at $0.05 to $0.15 per share and will expire in one year. As a result, the Company recorded a note discount of $1,118,000 to account for the relative fair value of the warrants, the notes’ beneficial conversion feature (BCF), and original issue discount (OID). The note discounts are being amortized over the term of the note or amortized in full upon the conversion to common stock. During the six-month period ended June 30, 2019 notes payable of $2,045,000 were converted into 38,406,486 shares of common stock.

 

As of June 30, 2019, total outstanding notes payable amounted to $1,073,000, accrued interest of $151,000 and unamortized note discount of $369,000 for a net balance of $855,000. A total of nine notes in the aggregate of $491,000 have reached maturity and are past due.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.19.2
6. Research and Development
6 Months Ended
Jun. 30, 2019
Research and Development [Abstract]  
Research and Development

  6. Research and Development

 

The Company constructs, develops and tests the AOT technologies with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as license fees, prototype equipment fabrication and installation, purchase of test equipment, pipeline pumping equipment, crude oil tank batteries, viscometers, SCADA systems, computer equipment, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company’s AOT prototypes.

 

Costs incurred for research and development are expensed as incurred. Purchased materials that do not have an alternative future use are also expensed. Furthermore, costs incurred in the construction of prototypes with no certainty of any alternative future use and established commercial uses are also expensed.

 

For the six-month periods ended June 30, 2019 and 2018, our research and development expenses were $583,000 and $95,000 respectively. For the three-month periods ended June 30, 2019 and 2018, our research and development expenses were $432,000 and $48,000 respectively.

 

AOT Product Development and Testing

 

The Company constructs, develops and tests the AOT technologies with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as prototype equipment fabrication and installation, testing fees, purchase of test equipment, pipeline pumping equipment, crude oil tank batteries, viscometers, SCADA systems, computer equipment, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company’s AOT prototypes.

 

During the six-month periods ended June 30, 2019 and 2018, the Company incurred total expenses of $489,000 and $1,000, respectively, in the manufacture, delivery and testing of the AOT prototype equipment. During the three-month periods ended June 30, 2019 and 2018, the Company incurred total expenses of $384,000 and $1,000, respectively, in the manufacture, delivery and testing of the AOT prototype equipment. Included in this amount, were costs related to a $500,000 work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized $450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019. There were no such expenses for the comparable period in 2018.

 

Temple University Licensing Agreement

 

On August 1, 2011, the Company and Temple University (“Temple”) entered into two (2) Exclusive License Agreements (collectively, the “License Agreements”) relating to Temple’s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the “First Temple License”), and to technology to reduce crude oil viscosity (the “Second Temple License”). The License Agreements are exclusive, and the territory licensed to the Company is worldwide and replace previously issued License Agreements.

 

Pursuant to the two licensing agreements, the Company paid Temple a non-refundable license maintenance fee of $300,000 and agreed to pay (i) annual maintenance fees of $187,500; (ii) royalty fee ranging from 4% up to 7% from revenues generated from the licensing agreements; and (iii) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. The term of the licenses commenced in August 2011 and will expire upon expiration of the patents. The agreements can also be terminated by either party upon notification under terms of the licensing agreements or if the Company ceases the development of the patent or fails to commercialize the patent rights.

 

Total expenses recognized during each six-month periods ended June 30, 2019 and 2018 pursuant to these two License Agreements amounted to $94,000 and $94,000, respectively. Total expenses recognized during each three-month periods ended June 30, 2019 and 2018 pursuant to these two License Agreements amounted to $47,000 and $47,000, respectively. Total expenses have been reflected in Research and Development expenses on the accompanying consolidated statements of operations. In the six-month periods ended June 30, 2019 and 2018, the Company also recognized penalty interest on past-due balances of $33,000 and $26,000, respectively, which is included as part of interest and financing expense in the accompanying statements of operations.

 

As of June 30, 2019 and December 31, 2018, total unpaid fees due to Temple pursuant to these agreements are $1,137,000 and $1,073,000, respectively, which are included as part of Accounts Payable – license agreements in the accompanying consolidated balance sheets. With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $1,002,000 are deemed past due. The Company is currently in negotiations with Temple to settle or cure the past due balance.

 

No revenues were earned from the two License Agreements during the six-month periods ended June 30, 2019 and June 30, 2018.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.19.2
7. Common Stock
6 Months Ended
Jun. 30, 2019
Stockholders' Equity Note [Abstract]  
Common Stock

  7. Common Stock

 

During the six months ended June 30, 2019, the Company issued 42,333,676 shares of its common stock as follows:

 

  · The Company issued 38,406,486 shares of its common stock upon the conversion of $2,045,000 in convertible notes pursuant to the convertible notes conversion prices of $0.05 to $0.15 per share.

 

  · The Company issued 3,138,993 shares of its common stock upon the exercise of warrants for proceeds of $202,000 at exercise prices of $0.05 to $0.18 per share.

 

  · The Company issued 538,197 shares of its common stock upon the exercise of options for proceeds of $71,000 at exercise prices of $0.08 to $0.18 per share.

  

  · The Company issued 250,000 shares of its common stock in exchange for $68,000 for services valued at $0.27 per share.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.19.2
8. Stock Options and Warrants
6 Months Ended
Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Stock Options and Warrants

  8. Stock Options and Warrants

 

The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. Options vest and expire according to terms established at the grant date.

 

Options

 

Options vest according to the terms of the specific grant and expire from 2 to 10 years from date of grant. The weighted-average, remaining contractual life of employee and non-employee options outstanding at June 30, 2019 was 5.2 years. Stock option activity for the period January 1, 2019 up to June 30, 2019, was as follows:

 

    Options   Weighted
Avg. Exercise
Price
 
January 1, 2019    35,301,300   $0.22 
Granted    4,687,500    0.08 
Exercised    (538,197)   0.13 
Forfeited         
June 30, 2019    39,450,603   $0.20 

 

The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest as of June 30, 2019 were as follows:

 

     Outstanding Options    Exercisable Options 
Option
Exercise Price
Per Share
    Shares    Life
(Years)
    Weighted
Average Exercise
Price
    Shares    Weighted
Average Exercise
Price
 
$0.05 - $0.24     17,915,553    8.0   $0.10    15,702,013   $0.10 
$0.25 - $0.49     20,913,552    2.8    0.27    20,913,552    0.27 
$0.50 - $0.99     471,052    4.8    0.85    471,052    0.85 
$1.00 - $2.00     150,446    4.1    1.18    150,446    1.18 
     39,450,603    5.2   $0.20    37,237,063   $0.21 

 

During the six-month period ending June 30, 2019, and pursuant to the Company’s Board Compensation policy approved by the Board June 19, 2015, the Company granted options to purchase 4,687,500 shares of common stock to members of the Company’s Board of Directors. The options are exercisable at $0.08 share, vest monthly over a twelve-month period, and expire ten years from the date granted. Total fair value of these options at grant date was $328,000 using the Black-Scholes Option Pricing model with the following assumptions: life of 5 years; risk free interest rate of 2.5%; volatility of 122% and dividend yield of 0%.

 

During the six-month periods ended June 30, 2019 and 2018, the Company recognized compensation costs based on the fair value of options that vested of $183,000 and $535,000 respectively. During the three-month periods ended June 30, 2019 and 2018, the Company recognized compensation costs based on the fair value of options that vested of $85,000 and $102,000 respectively.

 

At June 30, 2019, the Company’s closing stock price was $0.24 per share. The aggregate intrinsic value of the options outstanding at June 30, 2019 was $2,553,000. Future unamortized compensation expense on the unvested outstanding options at June 30, 2019 is approximately $164,000 to be recognized through December 2019.

 

Warrants

 

The following table summarizes certain information about the Company’s stock purchase warrants activity for the period starting January 1, 2019 up to June 30, 2019.

 

    Warrants   Weighted Avg.
Exercise Price
 
January 1, 2019    21,055,355   $0.09 
Granted    9,099,204    0.08 
Exercised    (3,138,993)   0.07 
Cancelled    (1,302,362)   0.19 
June 30, 2019    25,713,204   $0.08 

 

The weighted average exercise prices, remaining contractual lives for warrants granted, exercisable, and expected to vest as of June 30, 2019 were as follows:

 

     Outstanding Warrants    Exercisable Warrants  
Warrant Exercise Price Per Share    Shares    Life
(Years)
    Weighted
Average Exercise Price
    Shares    Weighted
Average Exercise Price
 
$0.05 - $0.24    23,643,204    0.6   $0.06    23,577,204   $0.06  
$0.25 - $0.49    2,000,000    2.3    0.30    2,000,000    0.30  
$0.50 - $1.00    70,000    4.8    0.80    70,000    0.80  
     25,713,204    0.7   $0.08    25,647,204   $0.08  

 

In the six-month period ending June 30, 2019, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 8,999,205 shares of common stock with an exercise price of $.05 to $0.18 per share, vesting immediately upon grant and expiring one year from the date of grant (see Note 5, above).

 

In the six-month period ending June 30, 2019, the Company issued warrants to purchase 99,999 shares of common stock with an exercise price of $0.24 per share, vesting over three months and expiring two years from the date of grant as compensation under an independent consulting agreement. Total fair value of the warrants at grant date was $17,000 using the Black-Scholes model with the following assumptions: life of 2.3 years; risk free interest rate of 1.75%; volatility of 153% and dividend yield of 0%.

 

During the six-month period ended June 30, 2019, warrants to acquire 3,138,993 shares of common stock were exercised resulting in net proceeds to the Company of $202,000.

 

At June 30, 2019, the aggregate intrinsic value of the warrants outstanding was $4,231,000.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.19.2
9. Commitments and Contingencies
6 Months Ended
Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

  9. Commitments and Contingencies

 

There is no current or pending litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.19.2
10. Subsequent Events
6 Months Ended
Jun. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

  10. Subsequent Events

 

Conversion of Convertible Notes

 

From July 1, 2019 up to August 13, 2019, Company issued 329,560 shares of common stock upon conversion of previously issued convertible notes in aggregate value of $50,000.

 

Exercise of Warrants

 

From July 1, 2019 up to August 13, 2019, Company issued 362,500 shares of common stock upon the exercise of previously issued warrants for aggregate cash proceeds of $19,000.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.19.2
2. Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Consolidation Policy

Consolidation Policy

 

The accompanying consolidated financial statements of QS Energy Inc. include the accounts of QS Energy Inc. (the Parent) and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.

Going Concern

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the six-months ended June 30, 2019, the Company incurred a net loss of $3,740,000, used cash in operations of $1,833,000 and had a stockholders’ deficit of $1,524,000 as of that date. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2018 financial statements, has raised substantial doubt about the Company's ability to continue as a going concern.

 

At June 30, 2019, the Company had cash on hand in the amount of $711,000. Management estimates that the current funds on hand will be sufficient to continue operations through November 2019, or, subject to actual costs incurred implementing design modifications to our AOT demonstration project described in Part I, Item 2, October 2019. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain payments to a former officer and consulting fees, during the remainder of 2019 and beyond.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.

Basic and Diluted Income (Loss) per Share

Basic and Diluted Income (loss) per share

 

Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an antidilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the Company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. At June 30, 2019 and 2019, we excluded the outstanding securities summarized below, which entitle the holders thereof to acquire shares of common stock as their effect would have been anti-dilutive.

 

   June 30,
2019
   June 30,
2018
 
Options   39,450,603    37,301,300 
Warrants   25,713,204    5,006,355 
Common stock issuable upon conversion of notes payable   12,784,543    5,287,502 
Total   77,948,350    47,595,157 
Estimates

Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.

Revenue Recognition Policy

Revenue Recognition Policy

 

Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that supersedes nearly all existing revenue recognition guidance under current U.S. GAAP and replaces it with a principle-based approach or determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.

Research and Development Costs

Research and Development Costs

 

Research and development costs are expensed as incurred and consist primarily of fees paid to consultants and outside service providers, and other expenses relating to the acquisition, design, development and testing of the Company’s products. Certain research and development activities are incurred under contract. In those instances, research and development costs are charged to operations ratably over the life of the underlying contracts, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. Payments made pursuant to research and development contracts are initially recorded as advances on research and development contract services in the Company’s consolidated balance sheet and then charged to research and development costs in the Company’s consolidated statement of operations as those contract services are performed.

 

In January 2019, the Company paid $500,000 as a deposit under terms of a work order for work to be performed by a pipeline operator. During the period ended June 30, 2019, the Company amortized $450,000 of such amount as a research and development cost based on the progress of work performed as required by the contract, and has reflected the $50,000 remaining amount as Prepaid expenses and other current assets in the accompanying consolidated balance sheet as of June 30, 2019.

 

For the six-month periods ended June 30, 2019 and 2018 research and development costs were $583,000 and $95,000, respectively. For the three-month periods ended June 30, 2019 and 2018 research and development costs were $432,000 and $48,000, respectively.

Patent Costs

Patent Costs

 

Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT and Joule Heat products, all patent costs are expensed as incurred. During the six-month periods ended June 30, 2019 and 2018, patent costs were $9,000 and $12,000, respectively, which is included as part of operating expenses in the accompanying consolidated statements of operations.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statement presentation or disclosures.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.19.2
2. Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Antidilutive shares
   June 30,
2019
   June 30,
2018
 
Options   39,450,603    37,301,300 
Warrants   25,713,204    5,006,355 
Common stock issuable upon conversion of notes payable   12,784,543    5,287,502 
Total   77,948,350    47,595,157 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.19.2
4. Property and Equipment (Tables)
6 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
Property and equipment
   June 30,
2019
   December 31,
2018
 
Office equipment  $30,000   $30,000 
Furniture and fixtures   5,000    5,000 
Testing Equipment   37,000    37,000 
Leasehold Improvements   25,000    25,000 
Subtotal   97,000    97,000 
Less accumulated depreciation   (76,000)   (73,000)
Total  $21,000   $24,000 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.2
5. Convertible Notes (Tables)
6 Months Ended
Jun. 30, 2019
Debt Disclosure [Abstract]  
Convertible Notes and Warrants
  

June 30,
2019

(unaudited)

  

December 31,

2018

 
Balance due on convertible notes  $1,073,000   $1,886,000 
Accrued interest   151,000    123,000 
Subtotal   1,224,000    2,009,000 
Convertible note discount   (369,000)   (1,100,000)
Balance on convertible notes, net of note discounts  $855,000   $909,000 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.19.2
8. Stock Options and Warrants (Tables)
6 Months Ended
Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Stock options outstanding
    Options   Weighted
Avg. Exercise
Price
 
January 1, 2019    35,301,300   $0.22 
Granted    4,687,500    0.08 
Exercised    (538,197)   0.13 
Forfeited         
June 30, 2019    39,450,603   $0.20 
Options outstanding by Per Share Price
     Outstanding Options    Exercisable Options 
Option
Exercise Price
Per Share
    Shares    Life
(Years)
    Weighted
Average Exercise
Price
    Shares    Weighted
Average Exercise
Price
 
$0.05 - $0.24     17,915,553    8.0   $0.10    15,702,013   $0.10 
$0.25 - $0.49     20,913,552    2.8    0.27    20,913,552    0.27 
$0.50 - $0.99     471,052    4.8    0.85    471,052    0.85 
$1.00 - $2.00     150,446    4.1    1.18    150,446    1.18 
     39,450,603    5.2   $0.20    37,237,063   $0.21 
Warrants outstanding
    Warrants   Weighted Avg.
Exercise Price
 
January 1, 2019    21,055,355   $0.09 
Granted    9,099,204    0.08 
Exercised    (3,138,993)   0.07 
Cancelled    (1,302,362)   0.19 
June 30, 2019    25,713,204   $0.08 
Warrants outstanding by Per Share Price
     Outstanding Warrants    Exercisable Warrants  
Warrant Exercise Price Per Share    Shares    Life
(Years)
    Weighted
Average Exercise Price
    Shares    Weighted
Average Exercise Price
 
$0.05 - $0.24    23,643,204    0.6   $0.06    23,577,204   $0.06  
$0.25 - $0.49    2,000,000    2.3    0.30    2,000,000    0.30  
$0.50 - $1.00    70,000    4.8    0.80    70,000    0.80  
     25,713,204    0.7   $0.08    25,647,204   $0.08  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.19.2
2. Summary of Significant Accounting Policies (Details) - shares
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Antidilutive shares excluded from EPS 77,948,350 47,595,157
Options [Member]    
Antidilutive shares excluded from EPS 39,450,603 37,301,300
Warrants [Member]    
Antidilutive shares excluded from EPS 25,713,204 5,006,355
Convertible Notes [Member]    
Antidilutive shares excluded from EPS 12,784,543 5,287,502
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.19.2
2. Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2017
Net loss $ (1,458,000) $ (758,000) $ (3,740,000) $ (1,458,000)        
Cash flow from operations     (1,833,000) (676,000)        
Stockholders' deficit (1,524,000) (1,772,000) (1,524,000) (1,772,000) $ (989,000) $ (1,482,000) $ (2,004,000) $ (1,874,000)
Cash on Hand 711,000 493,000 711,000 493,000   $ 1,153,000   $ 204,000
Payment for deposit for work to be performed     500,000          
Amortization of prepaid deposit     450,000          
Research and development costs 432,000 48,000 583,000 95,000        
Operating expenses $ 655,000 $ 462,000 1,133,000 956,000        
Patent Costs [Member]                
Operating expenses     $ 9,000 $ 12,000        
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.19.2
3. Accrued Expenses and Accounts Payable (Details Narrative) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Accrued salaries of officers and fees due to members of the Board of Directors $ 0 $ 55,000
Former Executive [Member]    
Severance payable $ 267,000 $ 327,000
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.19.2
4. Property and Equipment (Details) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Property and equipment, gross $ 97,000 $ 97,000
Less: accumulated depreciation (76,000) (73,000)
Property and equipment, net 21,000 24,000
Office equipment [Member]    
Property and equipment, gross 30,000 30,000
Furniture and fixtures [Member]    
Property and equipment, gross 5,000 5,000
Testing equipment [Member]    
Property and equipment, gross 37,000 37,000
Leasehold Improvements [Member]    
Property and equipment, gross $ 25,000 $ 25,000
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.19.2
4. Property and Equipment (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 1,000 $ 9,000 $ 3,000 $ 17,000
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.19.2
5. Convertible Notes (Details) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Debt Disclosure [Abstract]    
Balance due on convertible notes $ 1,073,000 $ 1,886,000
Accrued Interest 151,000 123,000
Convertible notes payable, gross 1,224,000 2,009,000
Convertible note discount (369,000) (1,100,000)
Balance on convertible notes, net of note discount $ 855,000 $ 909,000
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.19.2
5. Convertible Notes (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Debt Disclosure [Abstract]      
Notes payable balance $ 1,073,000   $ 1,886,000
Unamortized discount 369,000   1,100,000
Convertible notes, face amount 1,230,000    
Proceeds from convertible notes 1,118,000 $ 318,000  
Discount on notes issued $ 112,000    
Warrants issued with notes, shares 9,000,000    
Discount on fair value of warrants, BCF and OID $ 1,118,000    
Debt converted, amount converted $ 2,045,000    
Debt converted, shares issued 38,406,486    
Accrued penalty interest $ 151,000   123,000
Convertible notes outstanding, net 855,000   $ 909,000
Debt in default $ 491,000    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.19.2
6. Research and Development (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Research and development expenses $ 432,000 $ 48,000 $ 583,000 $ 95,000  
Accounts payable - licensing agreement 1,137,000   1,137,000   $ 1,073,000
License revenue generated 0 0 0 0  
Interest and financing expense 371,000 248,000 2,024,000 407,000  
Amortization of prepaid deposit     450,000    
AOT Prototypes [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Research and development expenses 384,000 1,000 489,000 1,000  
Amortization of prepaid deposit 450,000        
Prepaid expenses 50,000   50,000    
Temple University License Agreements [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Research and development expenses 47,000 $ 47,000 94,000 94,000  
Accounts payable - licensing agreement 1,137,000   1,137,000   $ 1,073,000
Interest and financing expense     33,000 $ 26,000  
Temple University License Agreements [Member] | Accounts payable deferred [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Accounts payable - licensing agreement 135,000   135,000    
Temple University License Agreements [Member] | Accounts payable past due [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Accounts payable - licensing agreement $ 1,002,000   $ 1,002,000    
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.19.2
7. Common Stock (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2019
Jun. 30, 2018
Debt converted, shares issued   38,406,486  
Debt converted, amount converted   $ 2,045,000  
Proceeds from warrant exercises   273,000 $ 647,000
Stock issued for services, value $ 68,000 $ 68,000 $ 12,000
Stock issued for services [Member]      
Stock issued for services, shares issued   250,000  
Stock issued for services, value   $ 68,000  
Convertible Notes Payable [Member]      
Debt converted, shares issued   38,406,486  
Debt converted, amount converted   $ 205,000  
Warrant Exercises [Member]      
Stock issued upon the exercise of options or warrants, shares issued   3,138,992  
Proceeds from warrant exercises   $ 202,000  
Options Exercises [Member]      
Stock issued upon the exercise of options or warrants, shares issued   538,197  
Proceeds from options exercised   $ 71,000  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.19.2
8. Stock Options and Warrants (Details-Options Outstanding) - Options [Member]
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Beginning Balance | shares 35,301,300
Granted | shares 4,687,500
Exercised | shares (538,197)
Forfeited | shares 0
Ending Balance | shares 39,450,603
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares $ 0.22
Weighted Average Exercise Price, Granted | $ / shares 0.08
Weighted Average Exercise Price, Exercised | $ / shares 0.13
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares $ 0.20
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.19.2
8. Stock Options and Warrants (Details-Options by Exercise Price Per Share) - Options [Member] - $ / shares
6 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Outstanding Options    
Options outstanding 39,450,603 35,301,300
Life (Years), options outstanding 5 years 2 months 12 days  
Weighted Average Exercise Price, options outstanding $ 0.20 $ 0.22
Exercisable Options    
Options exercisable 37,237,063  
Weighted Average Exercise Price, options exercisable $ 0.21  
$0.05 - $0.24 [Member]    
Outstanding Options    
Options outstanding 17,915,553  
Life (Years), options outstanding 8 years  
Weighted Average Exercise Price, options outstanding $ 0.10  
Exercisable Options    
Options exercisable 15,702,013  
Weighted Average Exercise Price, options exercisable $ 0.10  
$0.25 - $0.49 [Member]    
Outstanding Options    
Options outstanding 20,913,552  
Life (Years), options outstanding 2 years 9 months 18 days  
Weighted Average Exercise Price, options outstanding $ 0.27  
Exercisable Options    
Options exercisable 20,913,552  
Weighted Average Exercise Price, options exercisable $ 0.27  
$0.50 - $0.99 [Member]    
Outstanding Options    
Options outstanding 471,052  
Life (Years), options outstanding 4 years 9 months 18 days  
Weighted Average Exercise Price, options outstanding $ 0.85  
Exercisable Options    
Options exercisable 471,052  
Weighted Average Exercise Price, options exercisable $ 0.85  
$1.00 - $2.00 [Member]    
Outstanding Options    
Options outstanding 150,446  
Life (Years), options outstanding 4 years 1 month 6 days  
Weighted Average Exercise Price, options outstanding $ 1.18  
Exercisable Options    
Options exercisable 150,446  
Weighted Average Exercise Price, options exercisable $ 1.18  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.19.2
8. Stock Options and Warrants (Details-Warrants Outstanding) - Warrants [Member]
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Warrants outstanding, beginning balance | shares 21,055,355
Warrants granted | shares 9,099,204
Warrants exercised | shares (3,138,993)
Warrants cancelled | shares (1,302,362)
Warrants outstanding, ending balance | shares 25,713,204
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares $ 0.09
Weighted Average Exercise Price, Granted | $ / shares 0.08
Weighted Average Exercise Price, Exercised | $ / shares 0.07
Weighted Average Exercise Price, Cancelled | $ / shares .19
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares $ 0.08
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.19.2
8. Stock Options and Warrants (Details-Warrant Exercise Price per Share) - Warrants [Member] - $ / shares
6 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Outstanding Warrants    
Warrants outstanding 25,713,204 21,055,355
Life (Years), warrants outstanding 8 months 12 days  
Weighted Average Exercise Price, warrants outstanding $ .07  
Exercisable Warrants    
Warrants exercisable 25,647,204  
Weighted Average Exercise Price, warrants exercisable $ 0.08  
$0.05-$0.24 Price Per Share [Member]    
Outstanding Warrants    
Warrants outstanding 23,643,204  
Life (Years), warrants outstanding 7 months 6 days  
Weighted Average Exercise Price, warrants outstanding $ .06  
Exercisable Warrants    
Warrants exercisable 23,577,204  
Weighted Average Exercise Price, warrants exercisable $ .06  
$0.25-$0.49 Price Per Share [Member]    
Outstanding Warrants    
Warrants outstanding 2,000,000  
Life (Years), warrants outstanding 2 years 3 months 19 days  
Weighted Average Exercise Price, warrants outstanding $ 0.30  
Exercisable Warrants    
Warrants exercisable 2,000,000  
Weighted Average Exercise Price, warrants exercisable $ 0.30  
$0.50-$1.00 Price Per Share [Member]    
Outstanding Warrants    
Warrants outstanding 70,000  
Life (Years), warrants outstanding 4 years 9 months 18 days  
Weighted Average Exercise Price, warrants outstanding $ 0.80  
Exercisable Warrants    
Warrants exercisable 70,000  
Weighted Average Exercise Price, warrants exercisable $ 0.80  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.19.2
8. Stock options and Warrants (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Share based compensation expense     $ 194,000 $ 245,000
Proceeds from warrant exercises     273,000 647,000
Warrants [Member]        
Aggregate intrinsic value of warrants outstanding $ 4,231,000   $ 4,231,000  
Warrants exercised     3,138,993  
Proceeds from warrant exercises     $ 202,000  
Options [Member]        
Options granted     4,687,500  
Option exercise price     $ 0.08  
Share based compensation expense 85,000 $ 102,000 $ 183,000 $ 535,000
Aggregate intrinsic value of options outstanding 2,553,000   2,553,000  
Unamortized compensation expense $ 164,000   $ 164,000  
Weighted average life of options     5 years 2 months 12 days  
Options [Member] | Board of Directors [Member]        
Options granted     4,687,500  
Option exercise price     $ 0.08  
Fair value of options at grant date     $ 328,000  
EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 100 222 1 false 30 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://qsenergy.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://qsenergy.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://qsenergy.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://qsenergy.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) Sheet http://qsenergy.com/role/CondensedConsolidatedStatementOfStockholdersDeficit CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://qsenergy.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - 1. Description of Business Sheet http://qsenergy.com/role/DescriptionOfBusiness 1. Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - 2. Summary of Significant Accounting Policies Sheet http://qsenergy.com/role/SummaryOfSignificantAccountingPolicies 2. Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - 3. Accrued Expenses and Accounts Payable - Related Parties Sheet http://qsenergy.com/role/AccruedExpensesAndAccountsPayable-RelatedParties 3. Accrued Expenses and Accounts Payable - Related Parties Notes 9 false false R10.htm 00000010 - Disclosure - 4. Property and Equipment Sheet http://qsenergy.com/role/PropertyAndEquipment 4. Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - 5. Convertible Notes Notes http://qsenergy.com/role/ConvertibleNotes 5. Convertible Notes Notes 11 false false R12.htm 00000012 - Disclosure - 6. Research and Development Sheet http://qsenergy.com/role/ResearchAndDevelopment 6. Research and Development Notes 12 false false R13.htm 00000013 - Disclosure - 7. Common Stock Sheet http://qsenergy.com/role/CommonStock 7. Common Stock Notes 13 false false R14.htm 00000014 - Disclosure - 8. Stock Options and Warrants Sheet http://qsenergy.com/role/StockOptionsAndWarrants 8. Stock Options and Warrants Notes 14 false false R15.htm 00000015 - Disclosure - 9. Commitments and Contingencies Sheet http://qsenergy.com/role/CommitmentsAndContingencies 9. Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - 10. Subsequent Events Sheet http://qsenergy.com/role/SubsequentEvents 10. Subsequent Events Notes 16 false false R17.htm 00000017 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) Sheet http://qsenergy.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. Summary of Significant Accounting Policies (Policies) Policies http://qsenergy.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - 2. Summary of Significant Accounting Policies (Tables) Sheet http://qsenergy.com/role/SummaryOfSignificantAccountingPoliciesTables 2. Summary of Significant Accounting Policies (Tables) Tables http://qsenergy.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - 4. Property and Equipment (Tables) Sheet http://qsenergy.com/role/PropertyAndEquipmentTables 4. Property and Equipment (Tables) Tables http://qsenergy.com/role/PropertyAndEquipment 19 false false R20.htm 00000020 - Disclosure - 5. Convertible Notes (Tables) Notes http://qsenergy.com/role/ConvertibleNotesTables 5. Convertible Notes (Tables) Tables http://qsenergy.com/role/ConvertibleNotes 20 false false R21.htm 00000021 - Disclosure - 8. Stock Options and Warrants (Tables) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsTables 8. Stock Options and Warrants (Tables) Tables http://qsenergy.com/role/StockOptionsAndWarrants 21 false false R22.htm 00000022 - Disclosure - 2. Summary of Significant Accounting Policies (Details) Sheet http://qsenergy.com/role/SummaryOfSignificantAccountingPoliciesDetails 2. Summary of Significant Accounting Policies (Details) Details http://qsenergy.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative) Sheet http://qsenergy.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative 2. Summary of Significant Accounting Policies (Details Narrative) Details http://qsenergy.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 00000024 - Disclosure - 3. Accrued Expenses and Accounts Payable (Details Narrative) Sheet http://qsenergy.com/role/AccruedExpensesAndAccountsPayableDetailsNarrative 3. Accrued Expenses and Accounts Payable (Details Narrative) Details http://qsenergy.com/role/AccruedExpensesAndAccountsPayable-RelatedParties 24 false false R25.htm 00000025 - Disclosure - 4. Property and Equipment (Details) Sheet http://qsenergy.com/role/PropertyAndEquipmentDetails 4. Property and Equipment (Details) Details http://qsenergy.com/role/PropertyAndEquipmentTables 25 false false R26.htm 00000026 - Disclosure - 4. Property and Equipment (Details Narrative) Sheet http://qsenergy.com/role/PropertyAndEquipmentDetailsNarrative 4. Property and Equipment (Details Narrative) Details http://qsenergy.com/role/PropertyAndEquipmentTables 26 false false R27.htm 00000027 - Disclosure - 5. Convertible Notes (Details) Notes http://qsenergy.com/role/ConvertibleNotesDetails 5. Convertible Notes (Details) Details http://qsenergy.com/role/ConvertibleNotesTables 27 false false R28.htm 00000028 - Disclosure - 5. Convertible Notes (Details Narrative) Notes http://qsenergy.com/role/ConvertibleNotesDetailsNarrative 5. Convertible Notes (Details Narrative) Details http://qsenergy.com/role/ConvertibleNotesTables 28 false false R29.htm 00000029 - Disclosure - 6. Research and Development (Details Narrative) Sheet http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative 6. Research and Development (Details Narrative) Details http://qsenergy.com/role/ResearchAndDevelopment 29 false false R30.htm 00000030 - Disclosure - 7. Common Stock (Details Narrative) Sheet http://qsenergy.com/role/CommonStockDetailsNarrative 7. Common Stock (Details Narrative) Details http://qsenergy.com/role/CommonStock 30 false false R31.htm 00000031 - Disclosure - 8. Stock Options and Warrants (Details-Options Outstanding) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-optionsOutstanding 8. Stock Options and Warrants (Details-Options Outstanding) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 31 false false R32.htm 00000032 - Disclosure - 8. Stock Options and Warrants (Details-Options by Exercise Price Per Share) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-optionsByExercisePricePerShare 8. Stock Options and Warrants (Details-Options by Exercise Price Per Share) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 32 false false R33.htm 00000033 - Disclosure - 8. Stock Options and Warrants (Details-Warrants Outstanding) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-warrantsOutstanding 8. Stock Options and Warrants (Details-Warrants Outstanding) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 33 false false R34.htm 00000034 - Disclosure - 8. Stock Options and Warrants (Details-Warrant Exercise Price per Share) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-warrantExercisePricePerShare 8. Stock Options and Warrants (Details-Warrant Exercise Price per Share) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 34 false false R35.htm 00000035 - Disclosure - 8. Stock options and Warrants (Details Narrative) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative 8. Stock options and Warrants (Details Narrative) Details 35 false false All Reports Book All Reports qsep-20190630.xml qsep-20190630.xsd qsep-20190630_cal.xml qsep-20190630_def.xml qsep-20190630_lab.xml qsep-20190630_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true ZIP 51 0001683168-19-002622-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-19-002622-xbrl.zip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